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Millions of people worldwide suffer from corneal blindness, with many of them facing 
the global shortage of high quality donor corneas. A variety of artificial corneas have been 
developed to combat this problem, and a few have already reached commercial level. 
Natural polymers have shown potential as materials for tissue-engineered corneas due to 
their good biocompatibility, availability and typically mild reaction conditions. The aim 
of this thesis was to develop and characterise two hyaluronan hydrogels with and without 
rat tail collagen I to be used as scaffolds for the regeneration of the corneal stroma. 
The hyaluronan components were modified to achieve two different types of hydrazone 
crosslinking. The hydrazide components of type A gels were modified using adipic acid 
dihydrazide (ADH), and the ones of type B with carbodihydrazide (CDH), both with their 
corresponding aldehyde derivatives. The collagenous and non-collagenous hydrogels 
were distinguished using suffixes 1 and 2. The characterisation itself consisted of me-
chanical, viscoelastic and optical analyses, as well as stability, degradation and swelling 
measurements. Cell viability tests guiding the development were conducted by a collab-
orating research group alongside the material optimisation process. 
The mechanical characteristics were expressed using second order elastic constants. The 
average values for gels A1 and A2 in respective order were (5.4 ± 1.1) kPa and (2.9 ± 
1.1) kPa, and the ones for gels B1 and B2 were (6.7 ± 1.0) kPa and (7.3 ± 1.1) kPa. The 
addition of collagen produced somewhat conflicting results, since it improved the me-
chanical resilience of type B gels and weakened type A gels, indicating that collagen 
might have interfered with the crosslinking efficiency of the polymers. The CDH-modi-
fied type B gels showed improved stability and controlled swelling behaviour in the phys-
iological environment. All the gels were transparent and with refractive indices between 
1.33 and 1.34, which is slightly lower than the one of the corneal stroma (1.38). Type B 
gels had higher refractive indices than type A, presumably due to their higher crosslink 
density. Preliminary results from custom transmittance measurements showed slightly 
decreased transparency in the collagenous gels, as was expected. Collagen-content also 
decreased the swelling as well as the rate of enzymatic degradation in both gel types. 
The results showed that the CDH-modified hyaluronan hydrogels were significantly more 
stable in the cell culture medium and had superior mechanical and optical properties com-
pared to the ADH-modified gels. Based on the results, type B gels could have potential 
to be developed into hydrogels for corneal regeneration in the future. However, further 
examination would still be necessary on the collagen used in this study. 
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Maailmanlaajuisesti miljoonat ihmiset ovat sokeutuneet sarveiskalvovaurioiden seurauk-
sena. Vakavimpia niistä hoidetaan yleisesti kuolleilta ihmisiltä saaduilla sarveiskalvosiir-
teillä, joiden puute kuitenkin vaikeuttaa potilaiden hoitoonpääsyä. Ongelman ratkaise-
miseksi on kehitetty keinotekoisia sarveiskalvoja, joista osa on jo kaupallisessa käytössä. 
Perustuen luonnonpolymeerien hyvään kudosyhteensopivuuteen ja neutraaleihin valmis-
tusolosuhteisiin tämän työn tavoitteena oli kehittää ja karakterisoida kaksi hyaluronaaniin 
perustuvaa hydrogeeliä sellaisenaan sekä rotan hännän kollageeniin yhdistettyinä. 
Hyaluronaanikomponentteja muokattiin kemiallisesti kahden eri tyypin hydratsoniristi-
sillan muodostamiseksi. Kumpikin geeli koostui aldehydi- ja hydratsidimodifioiduista 
komponenteista, jotka yhdessä muodostivat hydratsonisidoksen. Tyypin A geelien 
hyaluronihappoon liitettiin adipiinihapon dihydratsidiryhmä (ADH) ja vastaava aldehy-
diryhmä, kun taas tyypin B geelit modifioitiin karbodihydratsidiryhmällä (CDH) ja vas-
taavalla aldehydiryhmällä. Ei-kollageeniset ja kollageenia sisältävät geelit eroteltiin li-
säksi numeroilla 1 ja 2 vastaavassa järjestyksessä. Geelien karakterisointi sisälsi mekaa-
nisia, reologisia ja optisia mittauksia sekä stabiilisuus-, turpoamis- ja hajoamistestejä. So-
luyhteensopivuustestit suoritti BioMediTechin Silmäryhmä Tampereella. 
Geelien mekaanisia ominaisuuksia kuvattiin ns. toisen asteen elastisuusvakioilla, jotka 
geeleille A1 ja A2 olivat (5,4 ± 1,1) kPa ja (2,9 ± 1,1) kPa ja vastaavasti geeleille B1 ja 
B2 (6,7 ± 1,0) kPa ja (7,3 ± 1,1) kPa. Kollageenin lisäys tuotti ristiriitaisia tuloksia, sillä 
se vahvisti tyypin B geelejä, mutta heikensi tyypin A geelejä. Kollageenilla epäiltiin ole-
van vaikutusta geelien ristisilloittumiseen heikentämällä toisen geelityypin polymeerien 
ristisiltojen muodostumista. Tyypin B geelit olivat huomattavasti stabiilimpia fysiologi-
sissa olosuhteissa. Kaikki geelit olivat läpinäkyviä ja niiden taitekertoimet välillä 1,33–
1,34, mikä on hieman sarveiskalvon stroomaa (1,38) alhaisempi. Johtuen tiiviimmästä 
ristisilloittumisesta B-tyypin geelien taitekertoimet olivat suuremmat. Läpinäkyvyyttä 
tutkittiin modifioidulla transmittanssimittauksella, jonka perusteella todettiin kollageenin 
lisäyksen hieman heikentävän geelien läpinäkyvyyttä. Kollageeni myös hidasti geelien 
hajoamista ja alensi niiden turpoamisastetta. 
Tulosten perusteella CDH-modifioidut, tyypin B geelit olivat huomattavasti kestävämpiä, 
vakaampia ja optisesti parempia kuin ADH-modifioidut tyypin A geelit. Johtopäätöksenä 
voidaan todeta, että tyypin B geelit voisivat olla varteenotettava vaihtoehto silmän sar-
veiskalvovaurioiden korjaamiseen. Työssä esiintyneiden laatuongelmien vuoksi kolla-
geenin lisäämisen vaikutuksia tulisi kuitenkin tutkia vielä tarkemmin. 
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1. INTRODUCTION 
The cornea is the transparent ‘window’ into the eye, which contributes to a significant 
portion of its refractive power and provides protection to its delicate inner parts. As a 
tissue, the cornea is unique. To be able to produce a sharp image on the retina it possesses 
excellent refractive properties and, due to its avascularity, a metabolism that functions 
entirely through diffusion. The cornea is composed of a highly organised multilayer struc-
ture with five distinctive layers, which mainly consist of a variety of collagens and pro-
teoglycans. (Freegard, 1997; Ruberti et al., 2011) 
Since the cornea is the main immunological barrier between the external world and the 
eye, even minor ulcers may lead to serious infections, diseases or to a total loss of vision. 
Corneal diseases contribute to a remarkable part of blindness around the world, and their 
treatment often requires surgical intervention or even corneal substitution through allo-
genic transplantation (Whicher et al., 2001). The methods for corneal treatment are con-
stantly improving, but there is a serious shortage of available donor corneas in all parts 
of the world, especially in developing countries where the prevalence of corneal diseases 
and traumas is higher and the possibility to receive appropriate medical care might not be 
available for all. This creates an increasing need for new solutions that are affordable, 
safe and independent of corneal donors, which in turn proposes a challenge to the tissue 
engineers trying to battle this problem. 
With the progress in regenerative medicine, the development of tissue-engineered corneal 
substitutes has risen interest through the past decades, with applications ranging from 
natural materials and tissues to completely synthetic designs prepared from polymers cre-
ated through recombinant DNA technology. Many research groups in the field have con-
centrated on the use of natural polymers and different composite structures that aim to 
mimic the natural corneal tissue. However, the aim of this thesis was not to produce a 
full-thickness implant, or to recreate the complicated layered structure of the cornea, but 
rather to prepare a prototype of a material that could be used in the future as a substrate 
for healing stromal damages. By combining the ECM-like properties of a hydrogel with 
collagen – a protein highly abundant in the natural cornea – this study aims to come one 
step closer to create a cell-friendly material for corneal regeneration. 
For this thesis, two hyaluronan-based hydrogel materials were developed and combined 
with collagen I, which resulted in four different gel formulations. The aim was to create 
a material that meets the requirements set by the native corneal tissue, most importantly 
high biocompatibility, mechanical resilience and good optical properties. To evaluate gel 
performance in comparison to these requirements, an extensive array of material charac-
terisation methods was utilised. 
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The first part of the thesis is theoretical, and it presents background information about the 
aims and requirements for the materials to be developed, and gives an insight into the 
current state and challenges of the research in the field today. The experimental part of 
the thesis consists essentially of different material characterisations, which include me-
chanical, optical, viscoelastic and stability tests, as well as chemical structure analyses 
and controlled enzymatic degradation experiments. The different methods are described 
and the results presented and discussed on the basis of the criteria presented in the theo-
retical part. Additionally, some points of interest regarding the current challenges in hy-
drogel characterisation methods will be discussed further in the discussion chapter. 
The study was carried out for the Biomaterials and Tissue Engineering Group in Tampere 
University of Technology and for the Eye Group of BioMediTech, a joint institute of the 
University of Tampere and the Tampere University of Technology, concentrated on Bio-
sciences and Medical Technology. The study was a part of the Human Spare Parts re-
search program of BioMediTech. 
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THEORETICAL BACKGROUND 
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2. THE HUMAN CORNEA 
Apart from being the protective barrier between the eye and the external environment, the 
cornea provides much of the eye’s refractive power and helps the lens to produce a fo-
cused and sharp image on the retina. To make this possible, the cornea expresses some 
unique tissue features, such as high transparency, exceptional structural organisation, and 
the ability to maintain its immunological defence system without vascularisation (Free-
gard, 1997; Griffith et al., 2009). 
From the viewpoint of materials science, the cornea could be classified as a composite 
structure with highly anisotropic and heterogeneous properties. More specifically, the 
cornea could be described as a fibre-reinforced hydrogel material that gets its bulk prop-
erties from the water-rich extracellular matrix (ECM) and its mechanical resilience from 
the lamellae of highly-organised collagen fibres. Even though as a tissue the cornea is 
relatively acellular, it has cellular layers that are essential to its transparency by upkeeping 
its metabolism and the optimal level of hydration (Freegard, 1997). The sizes of corneal 
structural components are well below the wavelength of visible light, which also contrib-
utes to its excellent optical clarity (Freegard, 1997). 
The fact that the cornea is an avascular tissue brings up challenges for tissue engineers, 
whose aim is to mimic its features with scaffolds and implants. The task is not simple: 
creating a mechanically robust three-dimensional (3D) scaffold that enables a sufficient 
flow of nutrients and biomolecules to maintain the healthy corneal metabolism requires a 
very careful material design. 
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2.1 The multilayer structure of the cornea 
The cornea is a transparent cellular structure consisting of five distinctive layers: three 
cellular layers with two membranes separating them. The layers of the cornea from ante-
rior to posterior direction are epithelium, Bowman’s layer, stroma, Descemet’s membrane 
and endothelium. While the epithelium, the stroma and the endothelium are actual cell 
layers, Bowman’s layer and Descemet’s membrane are acellular basement membranes. 
The structure of the cornea is illustrated in Figure 2.1 below. (Freegard, 1997; Ruberti et 
al., 2011) 
Even though the cornea has five distinctive layers, most of its mechanical stiffness ac-
counts for the two layers most abundant in collagen: the stroma and the Bowman’s mem-
brane (Dupps & Wilson, 2006). In their article, Dupps & Wilson (2006) note that the role 
of Bowman’s membrane as a loadbearing structural component has been under discus-
sion, referring to a study done by Seiler et al. in 1992. The latter states that the removal 
of Bowman’s membrane does not actually cause any measurable changes in the mechan-
ical properties of the cornea, which were determined through uniaxial stress-strain anal-
ysis of corneal samples with and without Bowman’s layer (Seiler et al., 1992). Neverthe-
less, it can be concluded that the predominant component for corneal mechanical strength 
is the stroma. Apart from the actual tensile strength of the collagen fibres, some of the 
Figure 2.1. A representative illustration of the structure and the cell types of the human 
cornea (modified from Ghezzi et al., 2015). 
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most important factors contributing to its mechanical resilience are the orientation and 
branching between the different lamellae. The interlamellar branching provides increased 
resistance against shear forces, while the angular offsets of the lamellae add to cornea’s 
ability to resist the intraocular pressure (IOP) (Dupps & Wilson, 2006). 
The surface of the cornea has an aspherical geometry, which means that its anterior cur-
vature does not form a part of a sphere. Instead, the corneal curvature is steeper in the 
central area than on the edges, and its thickness increases towards the sclera. (DelMonte 
& Kim, 2011) The average corneal diameter in adults is approximately 11.0 – 12.5 mm, 
with the central thickness being about 0,5 mm (Rüfer & Schröder, 2005, cited in Ghezzi 
et al., 2015). 
Epithelium 
Epithelium consists of 5 to 7 layers of cells attached to each other with tight junctions. 
The cells on the surface layer have plate-like morphology and are known as the squamous 
cells. The bottom layer of the epithelium consists of the basal cells, which are the cells 
that have most recently differentiated from their stem cells, known as limbal epithelial 
stem cells (LESC). (DelMonte & Kim, 2011) Between the layers of basal and squamous 
cells are the wing cells. The name comes from their morphology, since the cells are on 
their way to turn from round basal epithelial cells into flat squamous cells and express 
relatively irregular shapes (DelMonte & Kim, 2011). The limbal epithelial stem cells, or 
LESCs, are situated in the limbus, the border of the sclera and the cornea, from where 
they migrate towards the central cornea as they differentiate (Ahmad, 2012). 
A healthy epithelium is essential for maintaining the transparency and good refractive 
properties of the cornea. Since the cornea does not have blood vessels, it doesn’t have as 
efficient immunological defence ability as vascularised tissue. The cells on the surface 
are tightly packed together, which helps the epithelium to prevent pathogens from access-
ing the inner layers of the cornea. Additionally, the corneal epithelium is in constant pro-
cess of self-renewal: as the squamous cells on the surface mature, they are shed into the 
environment with the tear fluid. The lost squamous cells are replaced by the underlying 
wing cells, which now become squamous cells. Therefore, the youngest cells are always 
the basal cells closest to Bowman’s layer. This renewal is presumed to be another way of 
defending the eye from microbes and harmful substances. (Ruberti et al., 2011) 
Stroma 
The stroma is the thickest layer of the cornea and is composed of extracellular matrix rich 
in orientated collagen fibres, corneal keratocytes and proteoglycans (Michelacci, 2003). 
Reaching from Bowman’s layer to Descemet’s membrane, stroma spans about 80–90 % 
of the total corneal thickness (80–85 % according to DelMonte & Kim, 2011, 90 % ac-
cording to Hassell & Birk, 2010). By weight, about 15 % of the stroma consists of colla-
gen, while the rest is mainly water and biomolecules (Hassell & Birk, 2010). Of all stro-
mal collagens, 75 % is of type I, which is why it was also used as one of the hydrogel 
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components in the experimental part of this thesis. In their article, Hassel & Birk state 
that apart from collagen I, the stroma has an unusually high amount of type VI collagen 
(17 % of stromal collagens) and smaller amounts of other types, like collagen VI and 
FACIT collagens. The transparency of the stroma is achieved through an exceptionally 
homogenous structure of collagen fibrils situated side-by-side in lamellae. These small, 
25–30 nm thick fibrils are regularly spaced and have highly uniform diameter, which 
minimises light scattering and makes the stroma transparent. Additionally, the type of 
lamellar orientation is also believed to be optimal for the reduction of light scattering. 
(Ruberti et al., 2011) 
Different types of corneal proteoglycans are located amongst the collagen fibrils, playing 
an important role in keeping the interfibrillar spaces even and in controlling the fibril 
diameters (Hassell & Birk, 2010). However, it has been noted (Komai & Ushiki, 1991, as 
cited in Ruberti et al, 2011) that the sizes of the lamellae are significantly different be-
tween the anterior and posterior parts of the stroma: The lamellae in the posterior are 
almost ten times wider and about two times thicker than the ones in the anterior part. 
Descemet’s membrane 
Descemet’s membrane is a thick basement membrane dividing the stroma and the endo-
thelium. It provides support for the posterior surface of the cornea, and is produced by 
the endothelial cell layer (Pavelka & Roth, 2010). Although Descemet’s membrane was 
once thought to have no distinguishable structure (Jakus, 1956), it has later proven to 
express many types of organisation characteristic only to this membrane, such as hexag-
onal lattices and ladder-like structures (Pavelka & Roth, 2010).  
Descemet’s membrane is rich in collagens IV and VIII, and is mainly composed of dif-
ferent kind of proteins, such as fibronectin and laminin, and of proteoglycans like hepa-
ran, dermatan and keratin sulphate. While collagen IV can also be found in many other 
basement membranes, the type VIII is relatively rare elsewhere in the body. However, in 
Descemet’s membrane, collagen VIII has been found essential for maintaining the phe-
notype of the endothelial cells residing on its surface. (Ihanamäki et al., 2004; Pavelka & 
Roth, 2010)  
Endothelium 
The posterior layer of the cornea is the endothelium, which is formed by a monolayer of 
cells with hexagonal shapes. Endothelium is an approximately 4-µm-thick layer of flat 
and tightly adhered cells with the main purpose of maintaining the relatively dehydrated 
state of the stroma, which is fundamental for its optical clarity. This mechanism keeping 
the stromal water-content steady at 78 % is known as deturgescence, fuelled by the os-
motic gradient created by the ion pumps of the endothelial cells. (Delmonte & Kim, 2011) 
The endothelial cells do not proliferate, but the cell density of about 3500 cells/mm2 at 
birth normally lasts throughout the lifetime of an individual, with approximately 0.6 % 
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decrease per year. Additionally, the remaining endothelial cells have the ability to stretch 
themselves over time to cover the space left by the dead cells. (Delmonte & Kim, 2011) 
Corneal collagens 
In the cornea, as in many tissues of the body, different collagens are the main structural 
elements maintaining its shape and mechanical strength. What makes the corneal collagen 
fibrils different from the ones in other tissues is their highly uniform diameter, spacing 
and arrangement in the stroma. This precise structure and complex orientation of the col-
lagen molecules are the principal reasons for the excellent transparency and high optical 
performance of the cornea. (Ihanamäki et al., 2004) 
Although a wide range of different collagens is present, collagen I is the predominant 
type of collagen in the corneal tissue. At least 22 separate collagen types have been iden-
tified in the human eye, with six of them being exclusively found only in the ocular tis-
sues. The collagen types characteristic to the corneal tissue apart from collagen I are the 
types V, VI, XII, XIII, XIV and XXIV. (Ihanamäki et al., 2004) 
2.2 Corneal defects and their causes 
Cornea has an essential role for helping the lens to create a focused image on the retina, 
as well as functioning as the outermost barrier between the external world and the eye. A 
failure in its immunological defence ability can lead to severe complications and even to 
complete loss of vision. In their review article, Whitcher et al. (2001) describe corneal 
diseases and injuries as some the most common causes of blindness in the world; second 
only to cataract, which is responsible for about 45 % of all the blindness worldwide. Alt-
hough corneal ulcers are generally caused by diseases or injuries, defects may also result 
from various genetic disorders or states of malnutrition, such as the lack of certain vita-
mins (Whitcher et al., 2001). The different origins of corneal defects will be presented 
briefly in the following paragraphs. 
Diseases 
Diseases account for most of corneal ulcers, including a large variety of bacterial, viral 
and fungal infections, physiological disorders and different syndromes. Because the cor-
nea is an avascular tissue, it heals relatively slow and its immune defence capabilities are 
inferior to the vascularised tissues of the body, making the cornea particularly susceptible 
to microbial infections and scarring (Whitcher et al., 2001). Additionally, Whitcher et al. 
note that the commonness of corneal diseases depends greatly on the economical and 
general situation of the country, and on the socioeconomic status of the patient, since 
effective care and eye clinics are often unavailable for many people in poor countries. 
Referring to an extensive review done by Négrel & Thylefors in 1998, Whitcher et al. 
(2001) state that the high prevalence of corneal diseases in the developing countries has 
even been described as a silent epidemic with a scale much larger than previously thought. 
Nevertheless, in both the developing and the developed countries there is currently a great 
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need for new treatment methods that could substitute the use of corneal keratoplasty and 
lessen the need for corneal donors. 
The world’s leading infectious disease causing blindness is trachoma, which is particu-
larly dangerous in developing countries where modern operating facilities and eye-banks 
are rare. Severe trachoma is normally treated with penetrating keratoplasty (PK), but with 
weak outcome due to major corneal vascularisation and ocular surface problems. Accord-
ing to Whicher et al., the most cost-efficient way to fight blindness caused by corneal 
diseases would be the development of comprehensive prevention programmes, especially 
in the developing countries. (Whitcher et al., 2001) 
Unfortunately, some diseases cannot be prevented. Genetic disorders are not as common 
as infectious corneal diseases, but can cause conditions that are very complicated to treat. 
Instead of destroying the corneal tissue directly, genetic diseases often cause failure in 
the systems that are essential to maintain a healthy cornea. The treatment of genetic cor-
neal diseases is a field that many research groups are focused on, involving advanced 
approaches in stem cell technologies and novel tissue engineering applications. An ex-
ample of a serious corneal disorder that can originate both from injuries and hereditary 
diseases is the limbal stem cell deficiency (LSCD). LSCD is a term for severe corneal 
diseases that result from failure of the LESCs located at the border of the cornea and the 
sclera, which are responsible for maintaining the barrier between the transparent cornea 
and the vascular conjunctiva, and the renewal of the epithelium (Ahmad, 2012). If the 
LESCs stop regenerating, the conjunctival blood vessels invade the cornea and make it 
opaque, resulting in the loss of vision. Delivery of regenerated stem cells into the cornea 
inside or on the surface of a hydrogel, alike the ones presented in this thesis, could be one 
of the possible treatments for the LSCD in the future. 
Injuries 
The most common corneal injuries are scratches, cuts, chemical burns and contact lens 
problems. Statistically corneal injuries are not as common cause of blindness as diseases, 
because most of them are minor enough to be treated and healed through surgery or other 
means. Also, injuries often cause only monocular loss of vision rather than complete 
blindness, which means that the patients are not considered blind but only visually disa-
bled (Négrel & Thylefors, 1998). However, even a minor corneal ulcer provokes a sig-
nificant risk of infection, which may further on lead to a corneal disease and blindness. 
The occurrence of corneal injuries is especially high in areas with unrest and war in their 
recent history, where undetonated land mines and other weapons still cause injuries to 
civilians. Additionally, in developing countries corneal traumas caused by poor working 
conditions are especially high, which is why the most efficient approach in avoiding cor-
neal blindness would be through different prevention programmes. (Whitcher et al., 2001; 
Négrel & Thylefors, 1998) 
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3. HYDROGELS FOR CORNEAL REGENERATION 
Hydrogels are three-dimensional polymer networks with the capability of absorbing large 
amounts of water into their structure. Properties that mainly characterise a hydrogel and 
its swelling behaviour are the type and density of the crosslinks between its polymer 
chains. Based on this, hydrogels are generally classified into two groups: chemically 
crosslinked, ‘permanent’, and physically crosslinked, ‘reversible’, hydrogels (Hennink & 
Nostrum, 2002). Covalently bonded chemical crosslinks are typically stronger than phys-
ical crosslinks, which normally result from entanglements between the polymer chains, 
hydrogen bonds or other weak interactions between the molecules (Hennink & Nostrum, 
2002). Apart from the type of bonding, crosslink density has a great effect on hydrogel 
stability and swelling. In this thesis, the focus is on chemical hydrogels utilizing so-called 
pseudo-click reactions between differently modified hyaluronan components. 
Some of the most interesting features of hydrogel materials are their cell-friendly proper-
ties and similarity to the living tissue. Through incorporation of living cells into a hydro-
gel, researchers aspire to create fully degradable scaffolds that eventually would be re-
placed with healthy tissue generated by the cells inside. The 3D structure of hydrogels 
allows the cells to arrange into an architecture resembling the native ECM, which has 
been found to promote tissue growth (Kontturi, 2014). Because of their high water-con-
tent, hydrogels are also expected to allow effective transport of nutrients and other meta-
bolic products of the cells, resembling the natural metabolism of the cornea, which func-
tions entirely through diffusion. Hydrogels can also be modified and prepared under mild 
conditions and without the use of strong solvents that might limit cell viability, which 
further improves their suitability for biomedical applications. Unlike many other scaffold 
materials, hydrogels can often be delivered to the target site in minimally invasive ways, 
such as via injections. (Tan & Marra, 2010) 
When developing a hydrogel imitating the properties of the human cornea, the material 
requirements can be roughly categorised based on the basic requirements for an implant, 
such as biocompatibility, and for the special features needed from the ocular tissue. The 
main requirements for a corneal implant are presented in Figure 3.1 below. 
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Mechanically the cornea is very much like a hydrogel material. As described in Chapter 
2.1, the cornea can be generally thought as a composite material consisting mainly of 
collagens, ECM and cells. Following this logic, the optimal material for this type of ap-
plication would be a cell-friendly hydrogel matrix incorporated with collagen and ECM-
producing cells. As new tissue is formed, the material should also degrade without releas-
ing any undesirable by-products into the body. The purpose of the cornea is to provide 
refractive power for the eye, for which it expresses high transparency and good optical 
properties. Therefore, sufficient optical performance was also set as one of the material 
requirements. The importance of this requirement, however, was questioned afterwards 
(see Chapter 9.3) when evaluating the relationship between implant degradation and eye-
sight recovery times. 
3.1 Hyaluronan-based hydrogels 
Hyaluronan is a natural polysaccharide present everywhere in the body. It has a major 
role in organising and regulating the structure of the ECM, and controlling cell behaviour, 
such as their adhesion and morphology (Ossipov et al., 2010). It should be clarified that 
the term hyaluronan refers to all the physiological forms of the hyaluronic acid (HA), 
most commonly its sodium salt, while the term hyaluronic acid only refers to the actual 
HA compound. In this thesis, the term hyaluronan is primarily used, even when referring 
to the HA molecule itself. 
Mechanical 
properties
Optical 
performance
Biocompatibility Biodegradation
Figure 3.1. The most relevant material requirements to be considered for a hydrogel 
aimed for corneal applications. 
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3.1.1 Hyaluronan 
Hyaluronan has been used in clinical practice already for over 30 years, and is still being 
studied for a huge variety of tissue engineering applications (Burdick & Prestwich, 2011). 
What makes it even more interesting from the viewpoint of product development, HA is 
a readily available and low-cost biomaterial. However, in its natural form, the half-life of 
hyaluronan in the body is only a few days at maximum before it is degraded by hyaluron-
idase enzymes (Burdick & Prestwich, 2011). Therefore, in the development of medical 
products it is often necessary to improve its persistence and shelf-life by increasing its 
molecular weight or cross-linking ratio and density. 
The molecular structure of hyaluronan is highly conserved between mammalian species, 
consisting of two non-sulphated monosaccharide units: The D-glucuronic acid and the N-
acetyl-D-glucosamine (Bulpitt et al., 1999; Price et al., 2007). These building blocks can 
polymerise into exceptionally large macromolecules with molecular weights reaching 
over millions of grams per mole (Price et al., 2007). On its own, hyaluronan is water-
soluble and forms a gel when in contact with water. The viscoelastic behaviour of a HA-
water solution is shear-thinning, which is why HA has a role as a lubricant in cartilage 
tissue in the joints (Price et al., 2007). As a crosslinked network, it withstands the hydro-
lytic degradation caused by water, and swells instead, forming a hydrogel. The strength 
and swelling capability of this kind of a gel is mainly determined by the strength and 
density of its crosslinks. The chemical structure of the repeating disaccharide unit of hy-
aluronan is presented in Figure 3.2 below. 
The fact that hyaluronan is a biomolecule native to the human body makes it a specially 
promising material for tissue engineering, with applications ranging from neural tissue 
regeneration (Seidlits, 2010) to skin fillers (Gold, 2007), and extensive research ongoing 
for corneal applications (Burdick & Prestwich, 2011). Additionally, it can be chemically 
modified to obtain tailorable properties for different applications, for example through 
Figure 3.2. The chemical structure of the repeating hyaluronan disaccharide complex. 
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chemical conjugation of pharmaceuticals or preparation of HA-based nanocarriers. In ad-
dition, chemical crosslinking provides the means for controlling the mechanical proper-
ties and degradation rates of hyaluronan hydrogels. (Bulpitt et al., 1999; Ossipov et al., 
2010) Some examples of hyaluronan modifications are acrylation, esterification and dif-
ferent crosslinking methods. However, many of these strategies produce materials that 
are not suitable to be crosslinked in the physiological environment, or involve strong 
crosslinking agents that make them unfavourable to be used in the physiological environ-
ment. (Bulpitt et al., 1999) 
3.1.2 Modification and hydrazone-crosslinking of hyaluronan 
with functional aldehyde and hydrazide groups 
Some methods of hyaluronan modification completely lack the use of external crosslink-
ers. An interesting approach is to modify two hyaluronan components with different func-
tional groups capable of forming covalent crosslinks in the absence of additional cross-
linking agents. This type of catalyst-free crosslinking resembles ‘click chemistry’, a class 
of chemical reactions that was first time introduced by the group of Dr. Barry Sharpless 
at the annual meeting of American Chemical Society in 1999 (Hein et al., 2008). Since 
then, click chemistry has become increasingly popular and is used in many kinds of chem-
ical applications. It can be used for example to conjugate bioactive molecules into a pol-
ymer backbone, or to efficiently crosslink polymer chains together. The basis of click 
chemistry is in powerful reactions that involve simple reaction conditions, give high 
yields and do not require strong solvents. By definition, click chemistry products must 
also be easily purified and isolated, and stable under physiological conditions. (Kolb et 
al., 2001; Hein et al., 2008; Bulpitt et al., 1999.) 
To achieve this catalyst-free covalent crosslinking, a chemical reaction known as the hy-
drazone bond was utilized. A hydrazone bond is formed through a relatively simple cou-
pling reaction between aldehyde and hydrazide groups, and is typically characterised by 
its high yield, reversibility and excellent adaptability without requiring any harsh reaction 
conditions to occur (Jiang et al., 2014). 
The HA polymers were modified with functional hydrazide and aldehyde groups based 
on the methods presented by Oommen et al. (2013), Bulpitt et al. (1999) Martínez et al. 
(2011) and Jia et al. (2006). However, similar protocols have been described in other 
reports as well. Apart from modifying the components with these functional groups, two 
different types of both HA components were prepared utilizing two different methods of 
aldehyde and hydrazide modification. The HA derivatives with an ADH-modified hydra-
zide components (HA-ALD1 & HA-ADH) were prepared per the procedures of Jia et al. 
(2006) and Bulpitt et al. (1999), and the HA components with a CDH-modified hydrazide 
component (HA-ALD2 & HA-CDH) were prepared following the protocols of Martínez 
et al. (2011) and Oommen et al. (2013). 
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The hydrogel tests initially started solely with the gels involving the ADH-modification 
(later referred to as the type A), but were extended to the CDH-modified gels (type B) 
due to the insufficient stability of the type A gels. Apart from being more stable when 
immersed in the cell culture medium, type B gels also proved mechanically and optically 
better to the type A. The superior hydrolytic stability of the CDH-linkage owed to the 
adjacent nitrogen atom N3 providing resonance stabilisation to the CDH-bond. Oommen 
et al. describe (2013) this stabilisation analogous to the phenomenon known in chemistry 
as the ‘alpha effect’. (Oommen et al., 2013) 
Syntheses of the aldehyde-modified hyaluronan derivatives HA-ALD1 and HA-ALD2 
The aldehyde-modified component in type A gels, HA-ALD1, was produced by reacting 
HA with an equivalent molar amount of sodium periodate (NaIO4). This caused the oxi-
dation of the vicinal hydroxyl groups on the C2–C3 carbons of the glucuronic acid moiety 
of the HA complex, resulting in two aldehyde groups. The steps of the HA-ALD1 and 
HA-ALD2 modifications are illustrated in Figure 3.3 and Figure 3.4 below in respective 
order. 
Figure 3.3. Synthesis of the aldehyde-modified hyaluronan component HA-ALD1. 
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The gel type B aldehyde component, HA-ALD2, was modified through selective oxida-
tion of diol-modified HA. The main difference between the two modifications is that in 
the HA-ALD2 derivative the hyaluronan sugar ring structure was preserved, while the 
HA-ALD1 modification broke it to form the dialdehyde groups. Preserved ring structure 
provided the HA-ALD2 component with improved stability. 
Syntheses of the hydrazide-modified hyaluronan derivatives HA-ADH and HA-CDH 
The syntheses of the ADH and CDH-modified hyaluronan components, HA-ADH and 
HA-CDH, were both done by reacting the carboxylic groups of the HA molecule with an 
excess of either ADH or CDH in the presence of 1-hydroxybentzotriazole (HOBt) and 1-
Ethyl-3-[3-(dimethylamino)propyl]-carbodiimide (EDC). The ADH reagent creates a 10-
atom crosslink between the two hyaluronan polymers due to its internal aliphatic chain, 
while the CDH provides only a 5-atom bridge between the polymers. However, not hav-
Figure 3.4. Synthesis of the aldehyde-modified hyaluronan component HA-ALD2. 
16 
ing the aliphatic carbon chain gives the CDH-modified hyaluronan improved water solu-
bility compared to the ADH-modified component (Oommen et al., 2013). The chemical 
basis of the two hydrazide modifications are presented in Figures 3.5 and 3.6. 
 
  
Figure 3.5. Synthesis of the ADH-modified hyaluronan component. 
Figure 3.6. Synthesis of the CDH-modified hyaluronan component. 
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Hydrazone crosslinking of the modified hyaluronan components 
Upon mixing, the hydrazone bond is spontaneously formed between the aldehyde and 
hydrazide hyaluronan derivatives. This way two different gels, HA-ALD1 + HA-ADH 
and HA-ALD2 + HA-CDH, were formed. The representative chemical structures of both 
hydrogels are presented in the following Figures 3.7 and 3.8. 
Figure 3.7. Representative chemical structure of the hydrazone-crosslinked type A hy-
drogel from the HA-ALD1 and HA-ADH hyaluronan derivatives. 
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As can be seen from the hydrogel chemical structures, the most important differences are 
in the preserved ring-structure of the type B gel, and the longer molecular bridge between 
the hyaluronan polymers in the gel type A. 
3.2 Collagen-based hydrogels 
As presented in Chapter 2, the cornea has been described (Griffith et al., 2009) as a hy-
drogel material that composes mainly of collagen, cells and proteoglycans. Apart from 
functioning as a reinforcing component in a hydrogel matrix, its low immunogenicity and 
ability to promote tissue growth have made collagen a special subject of interest for tissue 
engineers, especially in ophthalmology. It has been studied for numerous corneal appli-
cations, including different co-polymeric scaffolds incorporated with collagen and ECM 
components to promote the production of collagen, as well as corneal implants composed 
primarily from collagen. (Wang & Spector, 2009; Xiao et al., 2013) In this chapter, an 
overview and a few examples of collagen-based hydrogels in regenerative medicine will 
be briefly presented. 
  
Figure 3.8. Representative chemical structure of the hydrazone-crosslinked type B hy-
drogel from the HA-ALD2 and HA-CDH hyaluronan derivatives. 
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Collagen hydrogels 
Collagen is abundantly available and has good properties to be used in a tissue-engineered 
corneal scaffold. Collagen spontaneously forms a gel when water is added, which makes 
it a relatively easy material to manufacture. It can work as a scaffold to culture corneal 
cells, such as stromal fibroblasts, which can proliferate and secrete new ECM material. 
(Borene et al., 2004; Shah et al., 2008) However, for corneal applications, collagen gels 
often require further processing to strengthen them, for example through compression 
(Xiao et al., 2014) and addition of crosslinking agents, which are often required to prevent 
rapid degradation of collagen in the physiological environment (Shah et al., 2008). 
The problems with collagens from natural sources have been the inconsistencies in their 
quality and the adverse immunological reactions they might cause in the recipient (Lynn 
et al., 2004). Recombinant technology could resolve these problems, but is still an expen-
sive method to use in large scale. In research, however, recombinant collagens in corneal 
applications have already shown promising results on both pre-clinical and clinical stages. 
Griffith et al. (2008) successfully manufactured hydrogel corneal substitutes from recom-
binant human collagens (RHC) I and III, which expressed similar properties to the native 
cornea. They showed high transparency, functional diffusion of nutrients and sufficient 
mechanical strength for implantation. During a 12-month in vivo study in pig models, 
these hydrogels supported the generation of nerves and tissue, and the proliferation of 
corneal cells. Although both collagen types possessed very similar properties, Griffith et 
al. reported that the RHC III implant showed superior strength and optical properties 
compared to the one of RHC I. (Griffith et al., 2008) 
Clinical tests have also been conducted for corneal substitutes made of RHC III. In con-
tinuance to the research of Griffith et al. (2008), Fagerholm et al. (2009) implanted the 
same materials in 10 human subjects, showing promising results after a 6–7-month fol-
low-up period. The operated eyes did not encounter adverse reactions, such as rejection 
or inflammation, and developed an even host-graft interface and smooth surface without 
distinguishable difference to the unoperated corneas. At the time of examination, the op-
erated eyes showed good tissue integration and normal ocular pressure, with constantly 
improving visual acuity and surface quality. Fagerholm et al. (2009) concluded the results 
to be highly encouraging, but note that more comprehensive and longer-term clinical tests 
would still be needed to properly evaluate the clinical potential of these biomimetic cor-
neal substitutes. 
Collagen-incorporated hydrogels 
There are numerous publications regarding collagen-based composite hydrogels targeted 
for ophthalmological applications. Many of them are copolymers that aim to composi-
tionally resemble the structure of the corneal stroma, and some consist of a collagen ma-
trix incorporated with cells and corneal ECM components (Borene et al., 2004; Myung et 
al., 2008).  
20 
In 2004, Borene et al. (2004) manufactured a prototype of a collagen-based stromal sub-
stitute incorporated with stromal fibroblasts, which showed features of natural wound 
healing response. The fibroblasts could migrate freely within the matrix and produced 
typical ECM molecules such as proteoglycans and collagen. In a study by Chen et al. 
(2005), a scaffold with a combination of collagen, chitosan and sodium hyaluronate was 
prepared and its biocompatibility was studied using rabbit corneal cells. With an optimal 
component ratio of 20 % collagen, 10 % chitosan and 0,5 % sodium hyaluronate the ma-
terial showed good cell response and optical clarity (Chen et al., 2005). 
Based on many publications, collagenous hydrogels have shown promising results and 
the use of different collagens has maintained its popularity among the development of 
biomimetic corneal substitutes. Through different processing and crosslinking strategies, 
the mechanical strength and biocompatibility of collagen-based scaffolds have been im-
proved over the time. Furthermore, the advances in recombinant technology will continue 
to improve the safety and quality of collagens used in artificial corneal substitutes. 
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4. CURRENT TRENDS IN CORNEAL APPLICA-
TIONS IN REGENERATIVE MEDICINE 
The treatment methods of corneal defects vary depending on the severity of the defect. 
Antibiotics, different ointments and tissue glues are some of the cures for minor ulcera-
tions, while the most serious corneal defects may require PK, deep anterior lamellar ker-
atoplasty (DALK) or artificial corneal substitutes. In the following chapters, these meth-
ods will be discussed along with the latest trends in modern regenerative medicine in 
corneal applications. 
4.1 Contemporary treatments and clinical applications for cor-
neal defects 
Keratoplasty 
Keratoplasty is a surgical operation in which a damaged cornea is replaced with an allo-
genic transplant. Depending on the severity of the defect, keratoplasty can be either la-
mellar, with only a layer of the cornea replaced, or penetrating, in which the whole cornea 
is received from a donor (Al-Yousuf et al., 2004).  
However, the demand for donors and good quality tissue surpasses their availability in 
many countries, which creates an increasing need for artificial corneal substitutes (Grif-
fith et al., 2009; Ghezzi et al., 2015). Moreover, the relatively common problems that can 
occur among corneal transplants, such as immunological rejection, infections and inflam-
mations, further increase the number of operations needed with corneal transplants. Even 
after a successful keratoplasty, the symptoms of rejection can cause severe and long-last-
ing discomfort for the patient, which can lead to the need of regrafting (Al-Yousuf et al., 
2004; Griffith et al., 2009; Ghezzi et al., 2015). 
Synthetic corneal substitutes 
A more advanced, although only provisional, solutions are fully synthetic corneal substi-
tutes known as keratoprostheses (KPros). KPros are often used when traditional kerato-
plasty cannot be performed, having the main purpose of helping the patient to recover a 
functional level of eyesight rather than actually healing the damaged cornea. (Griffith et 
al., 2009)  
Rather than being biodegradable, KPros are normally made from tissue-friendly, non-
biodegradable plastics combined with bio-inert metals like titanium (Griffith et al., 2009; 
Ghezzi et al., 2015). They are designed to have a clear centre with a porous perimeter that 
ensures attachment to the eye surface through fibroblast ingrowth. It is essential that the 
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synthetic materials used for KPros do not cause any adverse tissue effects that might de-
crease the tissue acceptance of the implant. To improve their biocompatibility, the most 
recent models of KPros utilise ECM components on their surfaces to enhance implant 
anchoring, as well as new kinds of materials to boost the nutrient and oxygen permeability 
of the implants. (Griffith et al., 2009) 
Amniotic membrane 
Amniotic membrane (AM) gained increasing attention as an option for treating conjunc-
tival ulcers in the 1940s, but its use was discontinued at that time due to the lack of suffi-
cient surgical techniques. However, with the development of modern methods of micro-
surgery and tissue engineering, AM has been brought back into use as a substrate for 
ocular reconstruction and as an ocular plaster to enhance wound healing. (Kruse et al., 
1999) 
The most important reasons for the use of the AM in regenerative medicine are its anti-
inflammatory and wound healing properties. It has been used both on its own to help 
healing and stabilising the corneal tissue after injuries, as well as accompanied with lim-
bal allografts to improve the outcome of the transplantation (Tseng et al., 1998). In their 
study, Tseng et al. (1998) tested the performance of the AM in these two cases in patients 
with different degrees of LSCD. The patients with moderate (5 patients, 7 eyes) or severe 
(13 patients, 14 eyes) limbal deficiency received both AM and allograft limbal transplan-
tation, while the patients with mild limbal deficiency (9 patients, 10 eyes) only received 
an AM transplantation. The results showed that the AM on its own is enough to heal the 
corneal surface and improve the vision in patients with only partial limbal deficiency, and 
combined with allogenic limbal transplant, able to enhance the success of the transplan-
tation. However, in the most severe cases of LSCD Tsung et al. found the tested methods 
with the AM insufficient, and that a PKP operation would need to be included for eyesight 
recovery. 
Although the AM has shown to be a potential substrate for corneal surface regeneration, 
the use of synthetically produced biomaterials would be a better option from the material 
aspect. Due to its natural origin, the properties of the AM cannot be specifically tailored 
nor homogeneity guaranteed. AM is not readily available and there is a possibility for 
immunological reactions. (Hopkinson et al., 2006) 
4.2 Current focus of research in corneal regenerative medicine 
Recent methods in the treatment of corneal defects utilise the techniques of modern re-
generative medicine, aiming to improve tissue growth through biodegradable implants, 
incorporated cells and growth factors combined with materials that mimic the features of 
the natural cornea. The regeneration of healthy tissue with minimal invasiveness and op-
timal biocompatibility of materials is a goal that researchers in this field pursue, and 
which novel corneal substitutes aim for using both synthetic and natural materials. 
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Many natural polymers have been studied for corneal applications. Apart from hyalu-
ronan and collagen, some examples are silk fibroin (e.g. Lawrence et al., 2009; Liu et al., 
2012; Hazra et al., 2016), alginate, chitosan (Liang et al., 2011) and gelatin (Tonsomboon 
et al., 2013). The use of natural materials has been both promising and problematic. Nat-
ural polymers are mostly non-toxic and can be processed in mild conditions, which im-
proves their tissue-friendliness, but on the other hand materials that do not naturally occur 
in the host tissue have the possibility of provoking serious immunological problems.  
To overcome biocompatibility and quality issues, large effort is currently put into the 
production of natural polymers through recombinant DNA (rDNA) technology, which 
makes it possible to produce biopolymers in the laboratory without the danger of trans-
ferring pathogens or encountering inconsistencies in the quality. Through genetic engi-
neering, rDNA technology aims to synthesize a desired product, such as collagen, in a 
host cell by modifying its DNA with sequences taken from two or more external sources. 
Sources to produce recombinant collagens can be bacteria, mammalian and plant cells, as 
well as silk worms or even transgenic tobacco. (Liu et al., 2008) 
Some research groups (Gaudreault et al., 2003; Guo et al., 2007; Proulx et al., 2010) have 
concentrated an approach known as self-assembling corneal substitutes, with the principle 
of letting cultured cells produce their own scaffold through the secretion of ECM products 
and macromolecules. Proulx et al. induced the production of collagen in dermal fibro-
blasts via the addition of ascorbic acid. The collagen produced by the cells was collected 
in the form of thin sheets, which were then stacked together to reproduce an arrangement 
resembling the lamellar structure of the native corneal stroma. On both sides of this arti-
ficial stroma, Proulx et al. seeded an endothelial and an epithelial cell layer, which was 
stratified by culturing the cells at air-liquid interface. The stratification of the epithelium 
was confirmed by identifying positive keratin 3 markers, which indicate a successful ep-
ithelial differentiation. In this stromal construct, all three corneal cell types – epithelial, 
stromal, and endothelial – were seeded. The resulting self-assembled cornea had similar 
optical characteristics to the natural cornea, and was fully free of any non-biological ma-
terials. The drawbacks of this technique, as summarised by Griffith et al. in their review 
on corneal substitutes (2009), are the slowness of the production and the almost certain 
need to use the receiver’s autologous cells, which further lengthens the process of implant 
manufacturing. 
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5. ARTIFICIAL CORNEAS – CLINICAL OUTCOMES 
AND FUTURE PERSPECTIVES 
Hydrogel materials have been a point of interest for corneal applications due to their 
aqueous 3D structure, highly modifiable properties and easy manufacturing and shaping. 
Currently, there are only few artificial corneas in clinical use, namely the Boston KPro, 
the AlphaCor® and the osteo-odonto-keratoprosthesis (OOKP), of which only the Alpha-
Cor® is made of a hydrogel material. Although most hydrogel corneal substitutes are still 
at the preclinical stage, new solutions are constantly emerging and proceeding towards 
clinical trials. In this chapter, the current commercial status and future prospects of arti-
ficial corneas are briefly discussed. 
The most widely used hydrogel corneal substitute is the AlphaCor®, previously known as 
the Chirila Keratoprosthesis, a device manufactured from synthetic poly(2-hydroxyethyl 
methacrylate) (PHEMA), and is currently the only hydrogel-based corneal substitute in 
commercial use. The AlphaCor® received the approval by the Food and Drug Admin-
istration (FDA) in 2002 and has proved to be a suitable option for patients with multiple 
failed corneal grafts or other serious complications that have made further grafting im-
possible. The implant is composed of a core optics and a porous skirt for tissue integra-
tion, and utilises interpenetrating polymer network (IPN) technology in the connection 
between its rigid core and porous skirt. This interesting design is based on the different 
types of behaviour of PHEMA depending on its water-content: the core of the AlphaCor® 
is manufactured from PHEMA with < 40% water-content, forming a clear, homogenous 
and mechanically robust hydrogel, while the skirt is prepared with a higher water-content, 
which results in a microporous, spongy gel. (Myung et al., 2008)  
In their review article, Myung et al. (2008) state that in successful cases, AlphaCor® has 
shown one-year retention rates of approximately 80 %, providing good eyesight perfor-
mance. Due to its lack of metal components, the AlphaCor® also has a more pleasant 
cosmetic appearance compared to the Boston KPro, for example. However, unlike the 
Boston KPro, the AlphaCor® requires a two-step implantation procedure, with the optics 
being exposed only after the second stage. Another drawback of the AlphaCor® is that 
PHEMA as a material cannot maintain a sufficient water content for the diffusion of nu-
trients to be efficient, which is why the AlphaCor® does not support the development of 
an epithelial cell layer on its surface (Myung et al., 2008). Referring to a review by Carls-
son et al. (2003), Myung et al. state that epithelial overgrowth has been found essential 
to prevent external particles and bacteria from contaminating the cornea due to the natural 
cellular barrier, resulting in less post-surgical complications. Therefore, epithelialisation 
is an important aspect in the development of artificial corneas today. (Myung et al., 2008) 
The Boston KPro, despite classified as an artificial cornea, requires a corneal graft from 
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a donor. This removes the problem of a missing epithelium, but involves risks of rejection 
or transferring of pathogens, similarly to a keratoplasty. 
Research in the field of corneal implants is thriving, and new alternative KPros are emerg-
ing, such as the KeraKlear® and the Miro Cornea®. Although only preliminary results 
from clinical trials have been reported, these devices have shown potential to rival the 
Boston KPro and the AlphaCor® as artificial corneal substitutes in the near future. Both 
products physically resemble soft contact lenses, and are manufactured from different 
acrylic-based biocompatible polymers. The Miro Cornea® is coated with genetically en-
gineered fibronectin to enhance its integration into the surrounding tissue (Duncker et al., 
2014). In a clinical study by Duncker et al., the Miro Cornea® was implanted into the eyes 
of four patients with corneal blindness, resulting in good tissue integration and stability 
during a 20–52-month follow-up period. Like the AlphaCor®, The KeraKlear® has a sin-
gle-piece core-and-skirt design, with 18 holes around its periphery to maintain tissue in-
tegration. Although some difficulties in implantation have been reported (Shrage et al., 
2014), it has already obtained the European CE marking, but is yet to receive the FDA 
approval for the U.S. market. Preliminary results for both newcomers are promising, but 
Shrage et al. conclude that more extensive clinical trials are still necessary to evaluate 
their long-term performance. 
Most of the artificial corneas are based on acellular scaffolds made of biocompatible pol-
ymers. However, contemporary research is getting more focused on the self-assembly 
approach, as briefly discussed in Chapter 4.2. Recently many biomaterials and tissue en-
gineering groups have been developing artificial corneas by inducing the cells to create 
their own ECM through the addition of different growth factors or other biomolecules. 
For example, by adding ascorbic acid in the cell suspension, Proulx et al. (2010) activated 
the production of collagen, which was then harvested and built from thin sheets into a 
multilayer scaffold. Apart from being tissue-friendly, this approach essentially removes 
the risk of pathogen transfer, which is often present when using collagen or other natural 
polymers from external sources. 
More recently a wider range of biomolecules have been used in self-assembling artificial 
corneas. Islam et al. (2016) recognised problems with the insufficient mechanical strength 
of self-assembled collagen scaffolds, and instead used smaller units known as collagen-
like peptides (CLP). The principle of using CLPs, as described by Islam et al., is in their 
ability to form collagen-like nanofibres with triple-helical structures, which can function 
as physical crosslinks in polymer systems or as 3D scaffolds on their own. As the basis 
for their study, Islam et al. used an article by O’Leary et al. from 2011, who used a peptide 
of 36 amino acids that mimicked collagen fibrils. However, the method was modified by 
adding a glycine spacer and an extra cysteine, which enabled covalent bonding with a 
branched PEG-maleimide polymer, which in turn was based on methods described by 
Perez et al. in 2011. Through this combination, Islam et al. could make the mechanical 
resilience of the hydrogel sufficient for surgical handling, describing the result as a good 
26 
combination of rigidity and flexibility. The materials were moulded into corneal shape 
and implanted in four mini-pigs by anterior lamellar keratoplasty. At 12 months after 
implantation, the eyes had remained stable and transparent apart from a mild haze in the 
implant-host interface. Showing similar morphology to the unoperated healthy eyes, stro-
mal tissue had grown inside and epithelial tissue on the surface of the implant. Addition-
ally, noticeable ingrowth of corneal nerves along with previously absent collagen I and V 
could be found inside the implants, indicating good host response and tissue integration. 
(Islam et al., 2016) 
With the intense research going on in corneal tissue engineering, novel solutions are fre-
quently discovered and new clinical data obtained from different types of designs. Fol-
lowing the path of pioneering products such as the AlphaCor®, hydrogel implants are still 
gaining increasing interest due to their cornea-like properties and great variety of features. 
In the pursuit of cornea-mimicking features, self-assembling and recombinant biopoly-
mers are showing the way for a very promising future in the field of corneal implantology. 
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6. AIM OF THE THESIS 
The overall purpose of this thesis was to develop a hydrogel material with controlled and 
defined properties that could provide a suitable platform for corneal cell proliferation and 
differentiation, while meeting the mechanical and optical properties required for such ap-
plication. Similar methods and materials have been described in multiple publications, 
but the basis for the polymers and gels prepared in this study is in the research done by 
Paul Bulpitt et al. in 1999, and O.P. Oommen and his group in 2013, who prepared gels 
from similarly modified hyaluronan components. The novelty value of this study comes 
from the incorporation of collagen into the hydrazone crosslinked HA structure and the 
wide range of characterisation methods used to study them. 
The main goals set for this Master’s thesis were: 
1. To develop a hydrazone-crosslinked hyaluronan hydrogel with optical function-
ality and suitable properties for corneal cell culturing and surgical application. 
2. To characterise the developed materials, with the focus being on their mechanical, 
viscoelastic and optical properties as well as hydrolytic stability and swelling ki-
netics. 
3. To compare the prepared hydrogels to similar materials found in literature, and to 
evaluate their potential to be used for corneal regeneration. 
The material development involved characterisation of the viscoelastic, mechanical and 
optical properties of the hydrogels, along with their swelling kinetics, stability and be-
haviour under air exposure. The mechanical properties of the hydrogels were measured 
using compression testing equipment, and their viscoelastic behaviour was tested in a 
cone-plate rheometer. Hydrogel transparency and refractive indices were determined us-
ing a fibre spectrometer and surface plasmon resonance equipment with customised test 
protocols. 
If a potential material filled the mechanical and optical requirements sufficiently, it con-
tinued to cell viability testing. The cell culture tests were conducted by the Eye Group of 
BioMediTech in Tampere, Finland, which is why the tests will not be discussed in greater 
detail within this thesis. However, the cell tests guided the development of the materials 
throughout the process, and often determined which material properties required improv-
ing and which gel formulations were to be developed further. 
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7. MATERIALS AND METHODS 
7.1 Materials 
Hyaluronic acid sodium salt from streptococcus equi (Mw 1.5 × 105 g/mol) was purchased 
from Lifecore Biomedical (Chaska, MN, USA). Adipic acid dihydrazide (ADH, Mw 
174.20 g/mol) and hyaluronidase (HAse) enzyme from bovine testes (type I-S, 400–1000 
U/mg) were purchased from Sigma Life Science (St. Louis, MO, USA). Sodium perio-
date, dimethyl sulphoxide (DMSO), ethylene glycol and 1-Ethyl-3-[3-(dimethyla-
mino)propyl]-carbodiimide (EDC) were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). 1-hydroxybentzotriazole (HOBt), 3-amino-1,2-propanediol and carbodihydrazide 
(CDH, Mw 90.08 g/mol) were purchased from Aldrich (St. Louis, MO, USA). Dialysis 
membranes (Spectra/Por cut-oﬀ 3500, 12–14 000 and 25 000 g/mol) were purchased from 
VWR International (Radnor, PA, USA). Collagen I used in the study was secreted from 
rat tails by a collaborating research group. Sodium chloride (NaCl), disodium phosphate 
(Na2HPO4) and sodium dihydrogen phosphate monohydrate (NaH2PO4 · H2O) used for 
PBS preparation were purchased from J.T. Baker® (Avantor Performance Materials, Cen-
ter Valley, PA, USA). Dulbecco’s Modified Eagle Medium was purchased from Gibco® 
(Thermo Fisher Scientific, Waltham, MA, USA). All solvents used in the study were of 
analytical quality. Milli-Q water was used in the syntheses and analyses. 
7.2 Modification of hyaluronan 
7.2.1 Syntheses of aldehyde-modified hyaluronans 
HA-ALD1 component 
The first aldehyde modification of hyaluronan (HA-ALD1) was carried out following a 
protocol reported by Jia et al. in their article (2006), from which a more detailed descrip-
tion can also be found. The goal for the modification was to form dialdehyde groups on 
the glucuronic acid moiety of the HA through periodate oxidation of its C2–C3 vicinal 
diols.  
Aqueous solutions of the HA periodate were mixed by adding the periodate drop-by-drop 
in room temperature, followed by mixing for four hours in the dark. Any unreacted peri-
odate was inactivated by adding ethylene glycol and stirring for another hour. The solu-
tion was then exhaustively dialysed against dH2O for three days, after which it was freeze-
dried to obtain the final HA-ALD1 product. 
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HA-ALD2 component 
The HA-ALD2 component was prepared as reported by Martínez et al. (2011). The pro-
cedure involved two stages: the first one involved a diol modification of the HA, followed 
by a selective oxidation of its diol groups into aldehyde functionalities in the second 
phase. 
First, the hyaluronic acid was dissolved in distilled water, followed by the addition of 3-
amino-1,2-propanediol and HOBt, which was pre-dissolved in 1:1 volume mixture of ac-
etonitrile and water. The pH was adjusted to 6.0 with 1 M HCl, EDC was added and let 
to stir overnight, after which the solution was dialysed for 24 hours against dilute HCl 
(pH = 3.0) containing 0,1 M NaCl, using a 3500 g/mol cut-off membrane. At this point 
the first product, the diol-modified HA, was lyophilised. 
The synthesis of the HA-ALD2 derivative initiated by dissolving the first phase product 
in distilled water. Sodium periodate (NaIO4), pre-dissolved in water, was added and let 
to stir for 5 minutes before ethylene glycol was added to quench the excess periodate. The 
solution was stirred for 2 hours and then dialysed (3500 g/mol cut-off membrane) for 24 
hours against distilled water. The final product was lyophilised and stored in a refrigera-
tor. 
7.2.2 Syntheses of hydrazide-modified hyaluronans 
HA-ADH component 
The ADH-modified hyaluronan component (HA-ADH) was prepared as described by 
Karvinen et al. (2017). The modified hyaluronan was created through the reaction of the 
carboxylic groups in its glucuronic acid element with and excess of adipic acid dihydra-
zide. 
The preparation started with dissolving sodium hyaluronate in distilled water overnight 
in a 100-ml three-neck flask. The following day a 30-fold molar excess of ADH was 
added, the pH was adjusted to 6.8 using 0.1 M NaOH or 0.1 M HCl and the system was 
connected to N2 atmosphere. HOBt and EDC were mixed together inside a glove box, 
dissolved in 1:1 (volume) DMSO/H2O and added to the mix. The pH was maintained at 
6.8 and the reaction was let to proceed overnight. The following day the pH was set to 
7.0 and the solution was dialysed for 3–5 days against distilled water with a 12–14 kDa 
MW cut-off membrane, after which the product was precipitated by adding NaCl and 
ethanol. Lastly, the HA-ADH precipitate was gathered, dissolved in water, freeze-dried 
and stored in a refrigerator. 
HA-CDH component 
The CDH-modified hyaluronan component was prepared per the method presented by 
Oommen et al. (2013), and has a similar protocol to the previously presented ADH-mod-
ification of hyaluronan. The main purpose of the modification was to make the carboxylic 
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groups in the HA react with an excess of carbodihydrazide in the presence of EDC and 
HOBt. 
The modification process began with dissolving 1 mmol of disaccharide repeat units of 
HA in distilled water and connecting the flask in N2 system. This was followed by the 
addition of the CDH and HOBt and adjusting the pH to 4.7 with 0.1 M NaOH of HCl. 
The EDC was weighed inside a glove box and added into the flask. The solution was 
mixed and left to proceed overnight. The following day the mixture was dialysed for 48 
hours against dilute HCl (pH = 3.5) containing 0,1 M NaCl, using a 3500 Da cut-off 
dialysis membrane. The resulted product was freeze-dried and stored inside a refrigerator. 
7.3 Preparation of hydrazone-crosslinked hyaluronan hydro-
gels 
Two different aldehyde and hydrazide modifications were done to the hyaluronan com-
ponents. The modifications were based on four different literature references with minor 
alterations. The hyaluronan derivatives with different modifications were named as 
shown in Table 7.1 below. Additionally, the non-collagenous and collagenous gel ver-
sions were distinguished with suffixes 1 and 2, in respective order. 
Table 7.1. Gel component abbreviations and their descriptions. 
Type Abbreviation Description Reference 
A 
HA-ALD1 Aldehyde-modified hyaluronan derivative. Jia, 2006 
HA-ADH 
Hydrazide-modified hyaluronan derivative, 
ADH modification. 
Karvinen et al., 2017 
B 
HA-ALD2 Aldehyde-modified hyaluronan derivative. Martínez et al., 2011 
HA-CDH 
Hydrazide-modified hyaluronan derivative, 
CDH modification. 
Oommen et al., 2013 
To find the optimal component concentrations and ratios for the gels, a total of 20 differ-
ent gel compositions were tested. The main properties observed during the preparation of 
different gels were the gelation speed and quality, the transparency and the mechanical 
stiffness of the gel. The mechanical rigidity was evaluated knowing the fact that the final 
products would need to withstand surgical handling without breaking or deforming. The 
variable parameters, such as different solvents, gelation platforms, component concentra-
tions and volume ratios were changed according to the results of the previous iterations. 
A list of all the tested gel formulations can be found in Table 7.2 below. 
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Table 7.2. A summary of gel formulations in the optimisation phase. The aldehyde deriv-
atives are titled A) HA-ALD and the hydrazide-modified components B) HA-HY. Values 
in parentheses indicate the polymer concentrations in milligrams per millilitre [mg/ml].  
Formulation 
Component 
amount (µl) 
Component solution 
W = Water 
P = PBS 
# A) HA-ALD B) HA-HY C) Collagen A B C A B C 
1 HA-ALD1 (20) HA-ADH (10) - 50 50 - W W - 
2 HA-ALD1 (20) HA-ADH (10) - 50 50 - P P - 
3 HA-ALD1 (20) HA-ADH (10) RAT (2) 50 50 25 W W 
Acetic 
acid 
4 - - RAT (2) - - 200 - - 
Acetic 
acid 
5 HA-ALD1 (25) HA-ADH (12,5) RAT (2) 50 50 25 W P 
Acetic 
acid 
6 HA-ALD1 (25) HA-ADH (12,5) RAT (2) 50 50 25 W 1:2 WP 
Acetic 
acid 
7 HA-ALD1 (25) HA-ADH (12,5) RAT (2) 50 50 25 W 1:1 WP 
Acetic 
acid 
8 HA-ALD1 (20) HA-ADH (10) RAT (2) 50 50 25 W 1:1 WP 
Acetic 
acid 
9 HA-ALD1 (25) HA-ADH (12,5) HUMAN (1) 50 50 25 W 1:1 WP 
Acetic 
acid 
10 HA-ALD1 (20) HA-ADH (10) HUMAN (1) 50 50 25 W 1:1 WP 
Acetic 
acid 
11 HA-ALD1 (25) HA-ADH (12,5) HUMAN (1) 50 50 50 W 1:1 WP 
Acetic 
acid 
12 HA-ALD1 (22,5) HA-ADH (11,25) - 50 50 - W 1:1 WP - 
13 HA-ALD1 (22,5) HA-ADH (11,25) HUMAN (1) 50 50 25 W 1:1 WP 
Acetic 
acid 
14 HA-ALD1 (22,5) HA-ADH (11,25) HUMAN (1) 50 50 50 W 1:1 WP 
Acetic 
acid 
15 HA-ALD1 (22,5) HA-ADH (11,25) RAT (2) 50 50 25 W 1:1 WP 
Acetic 
acid 
16 HA-ALD1 (22,5) HA-ADH (11,25) RAT (2) 50 50 50 W 1:1 WP 
Acetic 
acid 
17 HA-ALD2 (20) HA-CDH (20) HUMAN (1) 50 50 50 W 1:1 WP 
Acetic 
acid 
18 HA-ALD2 (30) HA-CDH (30) RAT (2) 50 50 25 P P 
Acetic 
acid 
19 HA-ALD2 (30) HA-CDH (20) HUMAN (1) 50 50 50 P P 
Acetic 
acid 
20 HA-ALD2 (30) HA-CDH (30) - 50 50 - P P - 
 
Through this type of iteration, the optimal gel compositions were determined and four 
different gels were chosen for further characterisation from each gel type: One collagen-
ous gel and one control gel without collagen. These four gel formulations are emphasised 
in bold in Table 7.2.  
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Therefore, the following four gels continued to the characterisation phase: 
A1:  HA-ALD1 (20) + HA-ADH (10) 
A2:  HA-ALD1 (22.5) + HA-ADH (11.25) + Rat tail collagen I (2) 
B1:  HA-ALD2 (30) + HA-CDH (30) 
B2:  HA-ALD2 (30) + HA-CDH (30) + Rat tail collagen I (2). 
As seen from Table 7.2, the optimal component ratios were 1:1 for gels A1 and B1, and 
2:2:1 for the gels A2 and B2, with collagen as the smallest ratio. The optimal mixing 
order of components was 1. HA-HY 2. Collagen 3. HA-ALD, since it was found that the 
mixing of collagen and the aldehyde modified hyaluronan caused the mixture to gelate, 
while a collagen-HA-HY solution remained liquid. This was presumed to be caused by 
the linking of the amino groups of the collagen molecules with the aldehyde groups of 
HA-ALD1 and HA-ALD2 derivatives, which resulted in premature crosslinking. 
For hydrogel preparation, the polymer components were dissolved in distilled water or in 
filtered PBS (pH = 7.4). Since no additional crosslinking agents were needed, the gels 
were prepared simply by mixing the aldehyde and the hydrazide components together. As 
mentioned above, in gels A2 and B2 the collagen solution was added to the hydrazide-
modified hyaluronan component before adding the aldehyde component. The gelation 
was done in an incubator at 37 ºC for 1 h. The determination of gelation speed was done 
using the so-called tube tilt test (ASTM International, 2011), in which the gel is prepared 
in a tube and tilted at different time points to determine when the gelation takes place. 
The recorded gelation time was the point at which the liquid stopped flowing as the tube 
was tilted. 
The gels tested with collagen I from human placenta performed poorly in cell culture 
tests, which is why their testing was discontinued. It appeared that the cells did not remain 
viable in the presence of the human collagen I, although no definite reason for this was 
found. A possible cause for this result could have been the low pH of the mild acetic acid 
solution of the human collagen I, or inconsistencies in its quality. 
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7.4 Hydrogel characterisation 
The properties of the hydrogels were characterised using a variety of test methods. Char-
acterised properties involved mechanical, chemical, optical and stability tests, as well as 
the evaluation of degradation and swelling behaviour in cell culture medium. Different 
material characterisation methods used for this thesis are summarised in Table 7.3 below. 
Table 7.3. An overview of the material characterisation methods used in this study. 
Characterisation Method 
Mechanical properties Compression test 
Viscoelastic properties Cone and plate rheometry 
Polymer chemical structure Fourier transform infrared spectroscopy (FTIR) 
Optical properties Refractive index (RI) measurement & fibre spectrometer 
Swelling kinetics Swelling Ratio measurement 
Enzymatic degradation Degradation by bovine testicular hyaluronidase 
Air exposure behaviour Cell culture inserts in a customised well plate 
7.4.1 Chemical structure 
The chemical compositions and the success of polymer modifications were verified using 
Fourier transform infrared spectroscopy (FTIR). One sample (V=100 µl, n=1) of each 
polymer component and of each gel was prepared in cut 1 ml syringes and lyophilised 
before testing. The samples in the FTIR measurements are presented in Table 7.4. 
Table 7.4. Components and gels characterised in the FTIR measurements. 
Aldehyde modified hyaluronans: HA-ALD1, HA-ALD2 
Hydrazide modified hyaluronans: HA-ADH, HA-CDH 
Collagen: Rat tail collagen I 
Hydrogels: HA-ALD1 (20) + HA-ADH (10) 
HA-ALD1 (22.5) + HA-ADH (11.25) + Rat collagen I (2) 
HA-ALD2 (30) + HA-CDH (30) 
HA-ALD2 (30) + HA-CDH (30) + Rat collagen I (2) 
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The testing was done at the Department of Chemistry and Bioengineering of Tampere 
University of Technology using a Spectrum One FT-IR Spectrometer (PerkinElmer, Wal-
tham, MA, USA) with Attenuated total reflection (ATR) sampling technique within 650 
to 4000 cm-1 wavelength range (0.5 to 64 cm-1 respective resolution). 
7.4.2 Mechanical and viscoelastic properties 
Compression tests 
The mechanical properties of the hydrogels were tested using a unidirectional, unconfined 
compression test at room temperature (r.t.) in air atmosphere. The compression tests were 
performed with BOSE Biodynamic Electroforce Instrument 5100 (Bose Corporation, 
Eden Prairie, MN, USA) equipped with a 225 N load cell, flat platens and a Wintest 4.1 
testing software. The platens were covered with Parafilm® and wet tissue paper to avoid 
sample drying and to hold the samples in place. A constant strain rate of 0.1 m/min 
(0.1666 mm/s) was used, and the compression was continued up to 70–75 % of maximum 
compressive strain. Examples of the compression test samples can be seen in Figure 7.1 
below. 
The samples (V = 875 µl, n = 5) were prepared in 5 ml cut syringes, which were closed 
using Parafilm® and gelated at 37 ºC for a minimum time of 1 h. Prior to the measurement, 
the samples were let to stand in room temperature for 24 hours after gelation to ensure 
gel uniformity. After removal from the syringe, the sample dimensions were measured 
Figure 7.1. Cylindrical samples (V = 875 µl) for the unconfined compression testing 
were prepared in cut 5 ml syringes. 
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using a digital vernier caliper. For each sample, the displacement and the scan time (= 
displacement divided by compression speed) were calculated according to sample dimen-
sions. For each sample, the number of data collection points, or scan points, was deter-
mined as the scan time multiplied by four. 
Through mechanical testing, it is possible to determine a solid material’s modulus from 
the slope of the linear elastic region of its stress-strain curve, which obeys Hooke’s law. 
However, because of the characteristic non-linear behaviour of hydrogels, the law does 
not apply other than at very low strain values. Instead, the values for so-called stiffness 
and second-order elastic constants were calculated for the hydrogels in this study, using 
the following methods described by Karvinen et al. (2017).  
Stiffness was defined as the derivative of stress with respect to strain, which in turn is the 
second derivative of energy density with respect to strain. The measured stress and strain 
values can be presented as the values of elastic constants using the following polynomial 
function: 
 
𝜎(𝜀) = ∑𝑐𝑘𝜀
𝑘
𝑛
𝑘=0
, (1) 
where σ is the stress, ε is the strain, and the coefficients ck are the elastic constants of the 
material. Consequently, the stiffness can be defined as 
 𝑑𝜎
𝑑𝜀
≡ 𝜏(𝜀) = ∑𝑘𝑐𝑘𝜀
𝑘−1
𝑛
𝑘=1
, (2) 
in which the value of ck is the second-order elastic constant (ck-1 would be the kth-order 
elastic constant). To generate the stiffness-strain curve, a 6th-degree polynomial function 
was fitted with the stress-strain graph of each sample, and the stress σ values were plotted 
as a function of strain ε. In other words, by plotting the stress-strain function (1) with the 
measurement data using the value n = 6 in the equation (1). The second-order elastic 
constants for each gel type were then calculated from the average stiffness-strain curves 
of parallel samples at 0–0.15 strain range by finding the stiffness value with the smallest 
relative standard deviation i.e. the smallest ratio between the standard deviation and its 
corresponding mean average stiffness value. The comparison between the stiffness func-
tions τ(ε) of different gels was done using polynomial (2) by plotting the stiffness τ values 
from equation (1) as a function of strain. (Karvinen et al., 2017) 
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Cone and plate rheometry 
The viscoelastic properties of the gels, such as the dynamic shear moduli, were evaluated 
in a Haake RheoStress RS150 rheometer with a RheoWin 4.3 software (Thermo Fischer 
Scientific, Waltham, MA, USA) in the material characterisation laboratory of the Depart-
ment of Materials Science in TUT. Cone and plate geometry (Type: 222-0598, cone angle 
= 1 º, diameter = 20 mm, gap = 0.8 mm) was utilized for all tests at a constant temperature 
of 37 ºC. The samples (V = 500 µl) for frequency sweep (n = 3) and amplitude sweep (n 
= 3) measurements were prepared in 20 ml cut syringes, made airtight with Parafilm® 
and gelated at 37 ºC for 1 hour. The measurements were conducted 24 hours after the 
gelation. 
Amplitude sweeps ( = 0.01–10, constant  = 1 Hz) were used to determine the linear 
viscoelastic region (LVR) of the gels, while the storage moduli G’ and loss moduli G’’ 
were measured using frequency sweeps (constant  = 0.1 (based on LVR),  = 0.1-10 
Hz). The measurements were controlled and the data collected with Haake Rheowin 4 
software. The collected rheometer data included the values for frequency, strain, storage 
and loss moduli, phase angle delta (δ) and tan δ. The tan δ expresses the internal friction 
of the material through the relationship between the loss and the storage modulus: 
𝑡𝑎𝑛⁡𝛿 = 𝐺′′/𝐺′. The strength of the hydrogel structure can be estimated using this value: 
if the measured tan δ < 0.1 the gel can be considered strong, and if tan δ > 0.1 the gel has 
a weak structure. 
7.4.3 Optical properties 
Refractive index 
The optical properties of the gels were evaluated by measuring their refractive indices 
and transparency. The RI of each gel type was determined with a surface plasmon reso-
nance equipment Navi 210A (BioNavis, Tampere, Finland). 
The device includes a goniometer and a laser light source, with which the sample surface 
can be scanned from different angles to determine its critical angle of total internal reflec-
tion. Different lasers were used, but all the calculations were done using 670-nm wave-
length. For the measurement, the procedure was modified so that no gold-plated sensor 
slide was used in the flow cell – as in an SPR measurement – but instead a glass sensor 
slide without any metal coating. The sensor slide, made of BK7 glass with a known RI, 
was used for device calibration before the measurement. In the calculations, a general RI 
value of nglass = 1.514 was used, based on a literature value given for BK7 glass at 670 
nm wavelength (Nakajima, 2015). After calibration, a sufficient amount of gel was ap-
plied on the flow cell to fill it thoroughly, and the flow cell was then tightened against the 
glass sensor slide as in the normal procedure. 
From this measurement, a curve of internal reflection for each sample was obtained, 
showing the reflection coefficient as a function of angle of incident, as will be presented 
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in Chapter 8.4.1. The RIs of the gels were determined from the curves utilizing equation 
(3) derived from Bragg’s law: 
 𝑛𝑔𝑒𝑙 =⁡𝑛𝑔𝑙𝑎𝑠𝑠×sin 𝛼, (3) 
where ngel and nglass are the refractive indices of the hydrogel and the sample slide, and α 
is the value of the angle of incident determined from the curve transformed into radians. 
Transparency 
Transparency of the hydrogels was evaluated visually during the optimisation phase. 
However, between different publications no widely-used or standardised protocol for 
measuring hydrogel transparency could be identified. To approach this problem, the prin-
ciple for a fibre spectrometer-based transparency testing method was developed as a part 
of this study. Even though in the scope of this thesis it was not possible to optimise the 
design and the testing protocol, the development this far will be described and discussed 
in the following paragraphs. 
The equipment for the transparency measurements consisted of a custom-fabricated sam-
ple holder and a JAZ spectrometer equipped with model QP400-1-UV-VIS fibre and a 
sample holder mount (Ocean Optics, Dunedin, FL, USA). The data was collected and 
processed using the related OceanView computer software. The mount and the optical 
fibre are shown in Figure 7.2. 
Figure 7.2. Fibre spectrometer equipment used in the hydrogel transparency measure-
ments. The sample holder is placed vertically in the gap indicated by the arrow, where 
the light beam passes through it horizontally. 
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The custom sample holder consisted of two standard microscopy slides and a piece of 
polydimethylsiloxane (PDMS) membrane (thickness = 800 µm) that was used to create 
wells to hold the gel samples. The design process started from defining the main require-
ments for the transparency measurement method, which included test repeatability, ac-
quisition of numeric output data, and the possibility to test samples with similar dimen-
sions to the native cornea. 
The standard samples used for the fibre spectrometer measurements are normally pre-
pared in cuvettes of 1–2 ml. Due to the material costs of the gels and to the inconvenient 
sample thickness for this purpose, a different sample holder needed to be made. Multiple 
designs were tested and further improved based on the results. 
To mimic the dimensions and shape of the cornea, thin hydrogel discs of a definite diam-
eter were to be prepared on a microscopy slide. This way the transparency could be meas-
ured through the glass and the hydrogel, using a clean spot of the same microscopy slide 
as the reference value and in device calibration. The diameter of the gels was controlled 
by using a punch tool with 10 mm diameter to make holes on the PDMS film and attaching 
it on the surface of the microscopy slide. The membrane would self-attach on the glass 
surface as it was placed there, after which the gels were prepared in the wells formed by 
the bottom glass and the PDMS walls. To ensure uniform sample thickness, another mi-
croscopy slide was attached on the opposite side so that the PDMS film and the samples 
would remain compressed between the two glasses. An illustration of the sample holder 
used in the measurements is presented in Figure 7.3 below. 
Figure 7.3. Illustration of the custom-fabricated sample holder for fibre spectrometer, 
used in hydrogel transparency measurements. 
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As will be described further in the results section, the design functioned well in principle, 
but would need some improvements with ensuring the parallelism of the microscopy 
slides and with securing the sample holder system on the spectrometer. Most of the in-
consistencies in the results were concluded to be caused by light reflection and scattering 
caused by the wrong alignment of the microscopy slides. 
7.4.4 Swelling behaviour 
The swelling of different gel types was evaluated in an experiment where the samples 
were immersed in DMEM/F-12 cell culture medium in 15 ml Falcon® tubes at 37 ºC. The 
swelling behaviour was observed during a period of 48 hours. 
The experiment was carried out with lyophilised hydrogel samples and with ‘fresh’ gels 
that were prepared one hour before the experiment. Three parallel samples (V = 125 µl, 
n = 3) of each gel were immersed in the medium and weighed at time points of 0, 1, 2, 4, 
6, 24 and 48 hours. A laboratory balance with 1 mg resolution was used for the swollen 
and fresh gels, while the lyophilized dry samples were weighed using an analytical labor-
atory balance with 0.01 mg resolution. A photograph of a gel B1 sample prior to its 6-
hour time point measurement is shown in Figure 7.4 below. 
Figure 7.4. A sample of gel B1 at its 6-hour time point during the non-lyophilised gel 
swelling experiment. The initially colourless and transparent samples obtained a pink 
hue as they absorbed the cell culture medium. 
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There are various ways to calculate the swelling ratio (SR) of hydrogels. In this case, the 
swelling ratios were calculated at each time point using formula (4) 
 𝑆𝑅 = (𝑊𝑠 −𝑊𝑑)⁡/⁡𝑊𝑑 ⁡, (4) 
where Ws is the mass of the swollen gel and Wd the mass after freeze-drying. The mass 
Wd of the lyophilised samples was obtained from time point 0, and the swollen sample 
mass Ws from the later time points.  In the case of the fresh gel samples, Wd was the mass 
of the gel when removing it from the syringe after one hour of gelation in the incubator. 
The resulting swelling ratio SR was plotted as a function of time to visualise the swelling 
kinetics of the gels, as presented later in Chapter 8.5. 
7.4.5 In vitro enzymatic degradation 
Hyaluronic acid is decomposed in the body by the hyaluronidase (HAse) enzymes. Sim-
ilar degradation was tested in vitro for the hydrogels using bovine testicular HAse type I-
S (400–1000 U/mg) dissolved in filtered PBS solution. The HAse concentration of the 
stock solution was 1 mg in 15 ml PBS. For each sample (V = 100 µl, n = 3) 0.75 ml of 
HAse solution and 1.25 ml of PBS solution were used, resulting in a final HAse concen-
tration of 20–50 U/mg. A parallel control sample for each gel was made and immersed in 
2.0 ml of filtered PBS. The samples were prepared in 1 ml cut syringes and gelated at 37 
ºC for 1 hour before immersing them into HAse-PBS solution in 15 ml Falcon® tubes.  
The enzymatic degradation was observed by weighing the samples at time points of 0, 2, 
4, 6, 24 and 26 hours. Prior to testing, the empty sample tubes were weighed, and at time 
point 0 the fresh gels were inserted into the empty tubes and the system was weighed. 
After this, the solutions were added and the gels were weighed at time points of 2, 4, 6, 
24 and 26 hours. A sample was concluded to be degraded when no gel was noticeable in 
the tube when removing the solution. 
7.4.6 Effects of air exposure 
When implanted in the cornea, the surface of the gels will be exposed to the surrounding 
air instead of being immersed in a liquid. Being exposed to air might cause possible 
changes in the dimensions, rigidity, transparency or other properties of the gels, which is 
why an experimental method was developed for hydrogel air exposure testing as a part of 
this thesis. 
For these experiments, a custom-fabricated apparatus was crafted using a 24-well plate 
and Millicell® Hanging Cell Culture Inserts with 1 µm pore size (Merck Millipore, Biller-
ica, MA, USA). The cell culture inserts were placed in the wells with their porous bottom 
in contact with the medium, while the top surface of the gel in the insert is exposed to air. 
This way the gels, intended to include cells in later experiments, absorb the medium only 
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through the pores in the base of the insert. To allow the cell culture medium to flow freely 
between the wells, the bottoms of the wells were cut off and passages were made between 
the wells and the peripheral edges of the well plate. The apparatus was placed on a petri 
dish and covered with a lid. During testing, the apparatus was incubated at 37 ºC and the 
gels were examined at different time points.  
Photographs of the apparatus without the gels and the medium are presented in Figure 7.5 
below, along with an illustration showing how the gels were situated within the inserts. 
It was noticed that the elevated temperature caused the medium to evaporate rapidly 
(within 24 hours), so it was necessary to place the apparatus inside a plastic bag accom-
panied with an open water container to maintain the humid atmosphere. Alternatively, the 
system could be placed in the incubator without a plastic bag by placing a large tray of 
water in the bottom of the incubator. 
After a desired time of air exposure, the surface and the edges of the gel were examined 
visually and with a microscope. To evaluate the possible changes in sample dimensions, 
such as shrinking, the edges and the surface of the samples were examined with a micro-
scope. To observe gel swelling and changes on the shape of the surface, the gels in the 
inserts were photographed from the side at different time points. 
 
Figure 7.5. Photographs of the empty system and a cross-sectional illustration of the 
custom-fabricated apparatus for hydrogel air exposure testing. The gels inside the inserts 
are presented in blue and the cell culture medium in orange. The whole system was placed 
in a petri dish and covered to avoid evaporation. 
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8. RESULTS 
8.1 Gel preparation 
A protocol for hyaluronan hydrogel preparation was successfully developed and the op-
timal compositions for the desired gel types were determined. All the formulations 
gelated within minutes from component mixing and showed sufficient transparency. 
From 20 different gel compositions 4 gels were chosen for further material characterisa-
tion and will be referred to as presented below: 
A1:  HA-ALD1 (20) + HA-ADH (10) 
A2:  HA-ALD1 (22.5) + HA-ADH (11.25) + Rat tail collagen I (2) 
B1:  HA-ALD2 (30) + HA-CDH (30) 
B2:  HA-ALD2 (30) + HA-CDH (30) + Rat tail collagen I (2). 
8.2 Chemical structure characterisation 
Fourier transform infrared spectroscopy (FTIR) was used to investigate the chemical 
compositions of the polymer components. The FTIR curves of the different gels are pre-
sented in Figure 8.1. below. 
Figure 8.1. FTIR curves of gels A1, A2, B1 and B2. 
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The characteristic signals identified from the FTIR curves for the gels and their compo-
nents are presented in Table 8.1 below. 
Table 8.1. FTIR signals identified for the characterised hydrogels and their components. 
Component / gel Characteristic signals (cm-1) 
HA-ALD1 1721 (ν(C=O) of 120 –C(O)H), 1620 (ν(C=O) of –NHC(O)– 
and C(O)OH) 
HA-ALD2 2890 (ν(C-H) of –C(=O)H), 1743 (ν(C=O) of –C(=O)H), 
1717 and 1636 (ν(C=O) of amide II), 1621 (δ(N–H) of -
NHC(=O)–), 1549 (δ(N–H) of amide II) 
HA-ADH 1705 (ν(C=O) of amide II), 1653 (δ(N–H) of amide and 
amine I), 1562 (δ(N–H) of amine and amide II), 1411 
(δ(CH2–C=O) of –CH2), 1077 (ν(C–N) of amine) 
HA-CDH 1744 (ν(C=O) of amide II), 1648 (ν(C=O) of amide II), 1613 
(δ(N–H) of amine I), 1415 (δ(N–H) of amide II), 1073 (ν(C–
N) of amine) 
Rat tail collagen I 3020 (ν(N–H) of amine II), 1635 (ν(C=O) of amide I), 1550 
(δ(N–H) of amide II), 1240 (δ(N–H) of amide III vibration 
modes), 1080 (ν(C–O–C) and 1033 ν(C–O) of carbohydrate 
moieties) 
HA-ALD1 (20) + HA-ADH (10) 1606 (ν(C=N) of the hydrazone bond) 
HA-ALD1 (22.5) + HA-ADH (11.25) 
+ Rat tail collagen I (2) 
1605 (ν(C=N) of the hydrazone bond) 
HA-ALD2 (30) + HA-CDH (30) 1609 (ν(C=N) of the hydrazone bond) 
HA-ALD2 (30) + HA-CDH (30) 
+ Rat tail collagen I (2) 
1609 (ν(C=N) of the hydrazone bond) 
Symbols: ν = stretching, δ = bending.  
 
In all the hydrogels, the disappearance of the aldehyde signal at 1721 and 1741 cm-1 is 
visible and a new signal from the crosslinking can be recognised at 1605–1609 cm-1, 
caused by the C=N stretching of the hydrazone bond. 
45 
8.3 Mechanical and viscoelastic properties 
8.3.1 Mechanical properties 
The mechanical characteristics of the hydrogels were determined using unconfined com-
pression testing. From the test data, obtained as the values for load and displacement, the 
stress-strain curves were calculated for each gel type and further used to calculate the 
stiffness of different materials. A representative stress-strain graph is presented in Figure 
8.2. 
Hydrogel stiffness was expressed with the value of their second-order elastic constants, 
which were calculated from equation (1). The average values for the second-order elastic 
constants of different gels are collected into following Figure 8.3.  
Figure 8.2. Representative stress-strain curves of the hydrogels from the unconfined 
compression measurements. For the stiffness calculations and sixth-order polynomial 
fittings, only values up to the fracture point were used from the stress-strain data. 
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However, for better visualisation and comparison between different strain values, the pol-
ynomial functions obtained from equation (2) are presented in relation to strain in Figure 
8.4 on the following page. 
In the case of the CDH-modified gels, the value of the second-order elastic constant ap-
peared to slightly increase as collagen was added, while the ADH-modified gels with 
collagen showed a significant decrease. This kind of behaviour was unpredicted, since 
collagen-content was expected to improve hydrogel stiffness.  
Although the second-order elastic constant can be used to describe the mechanical prop-
erties of the materials, it does not show how their behaviour changes with different strain 
values. Moreover, as emphasised in Chapter 7.4.2, these coefficients should be merely 
considered as estimations, since they were calculated from the average stiffness values at 
ε = 0–0.15 from the stiffness value with the smallest relative standard deviation. There-
fore, it is essential to rather evaluate the hydrogels’ mechanical behaviour from their com-
plete stiffness-strain curves, which are presented in Figure 8.4. 
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Figure 8.3. Average (n=5) second-order elastic constants of the different gel types. 
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As the stiffness-strain curves show, up to about 20 % strain levels the stiffness remains 
almost constant. After this, it builds up rapidly with the increasing strain value. The value 
of the second-order elastic constant for each gel was determined below strain values of 
0.15 at the average stiffness value with the lowest relative standard deviation. 
The type B gels showed superior mechanical properties compared to the type A, as seen 
in Figure 8.3. The second-order elastic constants of B1 and B2 were (6.7 ± 1.0) kPa and 
(7.3 ± 1.1) kPa, while the second-order elastic constants of gels A1 and A2 were only 
(2.9 ± 1.1) and (5.4 ± 1.1) kPa. 
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8.3.2 Viscoelastic properties 
The viscoelastic behaviour of the hydrogels was evaluated in rheological measurements. 
The linear viscoelastic region (LVR) of the gels was measured through amplitude sweeps, 
and the values of storage modulus (G’) and loss modulus (G’’) were determined from the 
linear region of the frequency sweep curves. These moduli express the way the material 
can resist shear forces, with G’ depicting the elastic and G’’ the viscous behaviour. 
The amplitude sweep graphs of different gels in Figure 8.5 below show that the LVR is 
maintained until 0.7–1.0 strain values, after which the storage modulus G’ decreases due 
to the breakdown of the material. 
The storage modulus G’ and the loss modulus G’’ are parallel in the linear viscoelastic 
region, which is an indication of a true gel structure. For an ideal gel, the storage modulus 
should have greater values than the loss modulus (G’ > G’’), which can be observed in 
the case of the tested gels as well. This signifies that the elastic behaviour of the material 
dominates its viscous behaviour. The results of the frequency sweep measurements are 
presented in Figure 8.6.   
 
Figure 8.5. Amplitude sweep measurement: average values (n=2). 
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Apart from gel B2, the moduli curves presented in the figure correspond to the results of 
the compression tests. The rheology results indicate that the shear moduli of gel B1 are 
greater than the ones of B2, while the second-order elastic constant had a higher value for 
gel B2.  
To describe the whole viscoelastic character of the gels, the values of the complex shear 
modulus G* and tan δ, the ratio between the viscous and the elastic modulus, are pre-
sented in Table 8.2. The modulus G* combines both the values of the elastic portion G’ 
and the viscous portion G’’ to describe the complete viscoelastic behaviour of the mate-
rial. 
Table 8.2. Average values of the complex modulus G* and tan δ in 0–1.0 Hz frequency 
range. 
Gel Average complex modulus G* at 0–1.0 Hz Average tan δ at 0–1.0 Hz 
A1 0.57 ± 0.02 kPa 0.022 ± 0.01 
A2 0.51 ± 0.03 kPa 0.027 ± 0.01 
B1 1.11 ± 0.34 kPa 0.107 ± 0.06 
B2 0.81 ± 0.19 kPa 0.082 ± 0.06 
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The value of tan δ is used to evaluate the strength of the gel structure (strong gel: tan δ < 
0.10, weak gel: tan δ > 0.10), as described in Chapter 7.4.2. Table 8.2 shows that gel B1 
exceeds this limit. However, because the surpass of tan δ value is only minor, the gel was 
still considered to have a strong gel structure. The greater tan δ value might have been 
caused for example by wetter gel surfaces in the rheology measurement samples, or by 
uneven mixing of the components. 
8.4 Optical properties 
8.4.1 Refractive index 
The data from the RI measurements was obtained as the values of reflection coefficient 
and angle of incident, which were used to calculate the refractive indices of different 
hydrogel samples. The full output graph can be seen in Figure 8.7. 
However, to determine the angle value that can be used for RI calculation, it was neces-
sary to examine the curve closer. The angle values used in the calculations were taken 
from the graph by drawing tangent lines on the vertical and horizontal parts of the curve, 
and determining the angle value at their intersection point. To do this graphical determi-
nation with sufficient accuracy, it was necessary to zoom in on the bends of the curves. 
The essential parts of the reflection coefficient vs. angle of incident-curves are presented 
in Figure 8.8 below. 
Figure 8.7. Internal reflection curves of the measured hydrogels from the refractive index 
measurements. 
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Figure 8.8 shows that compared to the curves of the other three gels, the curve of B2 is 
not as consistent at the section where the RI was determined from. To avoid error, it was 
necessary to zoom out and fit the tangent lines from further parts of the curve. 
The angle values for gels were determined visually from the enlarged curves, and the RI 
values were calculated using the formulae presented in Chapter 6.4.3. The angles of in-
cident, together with the RIs calculated with equation (3), are presented in Table 8.3 on 
the following page. 
It should be noted that this type of graphical method leaves a significant chance for er-
ror, which can be caused for example by an inaccurate vertical tangent line. Even a mi-
nor change in its direction will cause the angle value to change, which in turn alters the 
outcome from equation (3). 
Figure 8.8. Determination of the angles from the internal reflection curves for the calcu-
lation of hydrogel refractive indices. Angle values for gels A1, A2, B1 and B2 from the 
curves were 61.58, 61.91, 62.05 and 62.21, respectively. Note: A scale adjustment was 
necessary for gel B2 curve to achieve an appropriate tangent line fitting.  
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Table 8.3. The refractive index of the corneal stroma and the refractive indices of differ-
ent gels calculated from the RI measurement data. 
Gel Refractive index Angle value (º) 
A1: HA-ALD1 (20) + HA-ADH (10) 1.332 61.58 
A2: HA-ALD1 (22.5) + HA-ADH (11.25) + Col (2) 1.335 61.91 
B1: HA-ALD2 (30) + HA-CDH (30) 1.337 62.05 
B2: HA-ALD2 (30) + HA-CDH (30) + Col (2) 1.339 62.21 
Native corneal stroma (Patel et al., 1995) 1.38  
   
The RIs of the hydrogels were slightly greater than the one of water (RIwater = 1.33), but 
still less than of the native corneal stroma, which has an average RI of 1.38 (Patel et al., 
1995). Type B gels had slightly higher RIs than the ones of type A, presumably due to 
their higher crosslink density. The addition of collagen appeared to increase the RI value 
in both gel types. Overall, however, the differences were minor: only about 0.5 % between 
the highest (B2) and the lowest (A1) RI values. 
Even though type B gels showed higher RI values than the gels of type A, they still do 
not reach the RI of the natural corneal stroma, which is about 3 % greater. Based on the 
results, higher content of collagen I contributes to a higher RI, and could therefore im-
prove the refractive power of the hydrogel implant. However, since higher collagen con-
centrations in the gel optimisation phase resulted in haziness, some improvements would 
be needed in gel compositions. 
8.4.2 Transparency 
All the gels were considered sufficiently clear for ophthalmic applications based on visual 
inspection. As an example, a sample of gel B1 with 10 mm diameter and 1 mm thickness 
can be seen photographed in Figure 8.9 below.  
Figure 8.9. A type B1 hydrogel sample (10 × 1 mm) photographed on top of a printed 
text to demonstrate gel transparency. 
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Gel transparency was examined using a fibre spectrometer, as presented in Chapter 7.4.3. 
However, there are still major improvements needed for this testing method (see Chapter 
9.2), which is why the following results can only be considered suggestive. 
The transmittance measurement was conducted for the wavelength range of 300–1000 
nm, but with the purpose of evaluating gel transparency for the human eye it is reasonable 
to only examine the ‘visible light’ wavelengths of 400–700 nm. The transmittance of UV 
light would also be a sensible feature to measure for a material targeted for corneal appli-
cations, but was considered non-essential at this point of the development. 
The measurement was not carried out for all the characterised materials since the method 
was still incomplete, but an illustrative transmittance curve with gels A1 and A2 and the 
air reference is shown in Figure 8.10 below. 
Even though the method was lacking reliable repeatability, the results appear reasonable: 
the air reference used in calibration shows 100 % transmittance, while the collagen-free 
gel A1 shows superior transparency to its collagenous version, A2. The collagen content 
in the gels was assumed to increase opacity, which was also observed when optimising 
the gel compositions. Based on the limited transparency measurements conducted in this 
study, it can be presupposed that the concentration of collagen is inversely proportional 
to the transparency of the tested hydrogels. However, since the collagen concentration in 
the gels was relatively low, no considerable difference is shown in the transmittance lev-
els between the gels A1 and A2. 
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Figure 8.10. An illustrative figure of a transmittance measurement using a fibre spec-
trometer and a custom-fabricated hydrogel sample holder. 
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8.5 Stability and swelling kinetics 
The swelling test data was recorded and used for the calculation of mass-based swelling 
ratio for each gel type. The average SR values of three parallel samples were calculated 
at different time points and plotted as a function of time up to 48 hours. The test was 
conducted both for non-lyophilised and lyophilised samples immersed in cell culture me-
dium. The swelling test data for the lyophilised and non-lyophilised gels are presented in 
Figures 8.11 and 8.12 in respective order. 
The lyophilised gels showed greater resilience against swelling under the testing condi-
tions and lasted considerably longer than the non-lyophilised samples. The gels of type B 
maintained their geometrical shape throughout the test, and reached an equilibrium point 
where they remained until they dissolved through hydrolysis. Type A samples swell more 
vigorously and kept on absorbing the medium until their structure broke down and the 
gels broke in pieces. 
Figure 8.11. Hydrogel swelling kinetics in the cell culture medium: Average (n=3) swell-
ing ratio curves of the lyophilised samples. Due to a practical issue with the measure-
ments, the 24-hour time point for gel A2 is not included. 
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The swelling behaviour of the non-lyophilised samples differs considerably from the ones 
that were lyophilised. Even though the lyophilisation had made the samples more resistant 
to swelling, they experienced more dimensional deformation as they swell. The non-ly-
ophilised gels dissolved in shorter time, but managed to preserve better their original cy-
lindrical shapes. 
As seen from the swelling curves of the lyophilised gels in Figure 8.11, they seemed to 
reach a sort of ‘equilibrium’ level where the absorption slowed down considerably. By 
multiplying the average mass of the dry samples by the average SR value of this equilib-
rium plateau, it is possible to estimate whether the lyophilised samples recovered their 
original mass or if the freeze-drying process made them unable to return to their initial 
state. This kind of estimation was done, and it seemed that the lyophilised samples did 
not return to their original mass. This suggests that the lyophilisation possibly caused 
physical entanglements, structural collapses or other changes in the polymer network. The 
collagen content of gels A2 and B2 also decreased the value of the ‘equilibrium’ swelling 
ratio, when compared to the mass of the corresponding non-lyophilised gels. However, it 
should be noted that this kind of calculation is mere speculation, and cannot be used as 
an actual part of the characterisation. 
Figure 8.12. Hydrogel swelling kinetics in the cell culture medium: Average (n=3) swell-
ing ratio curves of the non-lyophilised gel samples. 
0.0
0.5
1.0
1.5
2.0
2.5
0 5 10 15 20 25 30 35 40 45 50
S
w
el
li
n
g
 r
at
io
, 
S
R
Time (h)
Gel A1 Gel A2 Gel B1 Gel B2
56 
8.6 In vitro enzymatic degradation 
The enzymatic degradation tests were conducted to ensure that the polymer modification 
had not affected the hyaluronan molecule in a way that would make it unrecognisable to 
the hyaluronidase enzymes. Until reaching complete degradation, the 100-µl gel samples 
(n = 3) were immersed in HAse-PBS solution which was changed after weighing at each 
time point. 
The rate of enzymatic degradation of each gel type is presented in Figure 8.13, where 
their average (n = 3) relative masses are plotted as a function of time. In type A gels the 
degradation was more visible after a period of swelling, which dominated their behaviour 
up to the 2-hour time point. After this, the gel mass decreased quite rapidly until the gels 
had been completely degraded by the enzymes between 6 and 24-hour time points. Type 
B gels resisted considerably better, lasting in the enzyme solution for over 28 hours. At 
the 48-hour time point, however, all the gels had been degraded by the enzymes.  
A slight, unusual decrease is visible at the 2-hour time point of gel B1. The surfaces of 
the gels had most likely dried more during weighing than at other time points, which 
resulted in smaller masses. Otherwise the curve of gel B1 closely follows the behaviour 
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Figure 8.13. Average (n=3) enzymatic degradation curves of the tested hydrogels. Gels 
A1 and A2 degraded completely between time points 6 h and 24 h, while gels B1 and B2 
degraded between time points 28 h and 48 h. 
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of gel B2. Type B gels also resisted the initial swelling better, and did not show similar 
mass increase in the first hours like type A gels. 
Collagen-content accelerated the rate enzymatic degradation of type A gels, while it 
slowed down the degradation of gel type B. However, the difference occurs most im-
portantly during the first hours, after which the degradation rates of collagenous and non-
collagenous gels seem to continue almost equal with both gel types.  
8.7 Air exposure behaviour 
The custom-fabricated apparatus performed as expected, allowing the gels to absorb me-
dium through the pores of the inserts. However, due to high absorption the gels tended to 
swell extensively and dissolve after a certain time. The behaviour was in line with what 
was observed in the swelling experiments described in Chapter 7.4.4, with a significant 
difference between the stability of the two gel types A and B. 
While all the gels absorbed the medium through the pores in the bottom of the insert and 
swell, the type A gels did not withstand the swelling for more than 3 days before they 
dissolved and disappeared from the inserts. Type B gels, on the other hand, kept on ab-
sorbing the medium and remained in the inserts as swollen gels throughout the 7-day 
experiment, as visible in Figure 8.14. 
Based on the results, the exposure to atmospheric conditions did not have any significant 
effect on the gels. The surfaces of the gels were also examined using optical microscopy, 
but no significant changes, such as drying or deformations, were visible. The dominating 
behaviour was clearly the absorption of the cell culture medium, which resulted in gel 
swelling and eventual dissolving caused by the breakdown of its crosslinked polymer 
network. Like in the swelling tests, gels A1 and A2 did not maintain their structure as 
well as gels B1 and B2, which lasted in the inserts considerably longer. 
Figure 8.14. Hydrogel air exposure experiment: Gel B1 after gelation (a), after 3 days 
(b) and after 7 days (c) in the insert. 
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9. DISCUSSION 
9.1 Evaluation of hydrogel properties for stromal regeneration 
In the scope of the characterisation methods carried out in this study, the designed hydro-
gels showed potential to be used as materials for stromal regeneration. Regarding the 
mechanical, rheological and optical properties the gels performed sufficiently well. The 
results from cell culture tests showed satisfactory performance for the hyaluronan hydro-
gels, whereas the gels containing collagen faced some problems with cell viability, pos-
sibly due to too acid pH values. 
9.1.1 Mechanical resilience 
The main requirements for the mechanical strength of the gels were the adequate rigidity 
and toughness for the gels to withstand handling during cell culturing and implantation. 
This requirement was met, since all the gels were sufficiently resilient to be manually 
handled throughout the characterisations. 
The results from the mechanical tests showed a noticeable difference between the gels 
with different hydrazide modifications, with the CDH-modified hyaluronans of type B 
showing improved mechanical resilience compared to the type A. However, even though 
the results of the mechanical tests revealed clear differences between gel types, they were 
less obvious while handling the gels in practice. All the gels withstood careful handling 
with tweezers and spatulas during the characterisation, although thin samples, such as the 
ones in rheology measurements, needed to be handled with special caution. Any sharp 
edges or shear stress, however, tended to break the gels easily. In the case of the ADH-
modified type A gels, increased toughness would be preferable if thin cornea-like slices 
or films were to be handled. The CDH-modified gels withstood elastic deformation better 
and could be handled more conveniently. 
It should be noted that the calculations for the second-order elastic constants are in fact 
estimates taken from the 0–0.15 strain range of parallel samples’ mean average stiffness 
values, choosing the value with the lowest relative standard deviation. This strain range 
includes both the so-called ‘toe region’ at very low strain values and a part of the non-
linear elastic behaviour, which intensifies after 0.15 strain (see Figure 8.4). Therefore, it 
is more recommended to analyse the mechanical properties of the gels rather by compar-
ing the actual stiffness-strain curves than concentrating too much on the values of the 
second-order elastic constants. 
The gels developed in this thesis can be prepared in physiological or in room temperature 
by mixing two hyaluronan solutions that crosslink without additional crosslinking agents. 
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Therefore, they can be applied not only as implants moulded into shapes, but also as in-
jections. In this case, a two-component gel could be used to fix stromal defects by directly 
injecting it into the corneal tissue from a double syringe. When injected, the mechanical 
strength of the gels would not have to be as high as if the gel was used as an already-
shaped implant, since most of the mechanical stress would obviously be caused during 
the surgical handling. If used as an injection, however, the resulting hydrogel could be 
softer, which might have opened new possibilities in the material development and opti-
misation phase, given it would still be sufficiently strong for corneal cell growth. 
A need for an improved gelation platform for the compression test samples was recog-
nised during the characterisation, since some difficulties occurred when removing the 
samples from the cut 5 ml syringes. As the gels were extruded from the syringes, the 
peripheral part of their surface tended to ‘peel’ due to entanglement on the syringe edge. 
Even though this did not break other than a small part of the gel edges, it could be con-
sidered as a minor source of error in the measurements. However, no differences were 
found in the test data between the intact samples and the ones with ‘peeled edges’. It 
might be possible to solve this problem by using some sort of lubricant on the syringe 
walls, but adding such agents might also affect the gels. A custom well plate made of 
polytetrafluoroethylene (PTFE) with openable well-bottoms was tested for this purpose 
– knowing the material’s low coefficient of friction – but the problem persisted. Addi-
tionally, the removal of samples from the well plate proved to be problematic compared 
to the syringes due to the lack of pistons. 
9.1.2 Stability, swelling and degradation of the gels in vitro 
Swelling and stability in cell culture medium 
The swelling tests were performed at physiological temperature for freshly gelated and 
for lyophilised gels by immersing the gels in cell culture medium and observing the 
changes in their weight as they absorbed water. From the measurements, mass-based 
swelling ratios were calculated and plotted in relation to time. The tests showed that there 
were significant differences in the stability of the gels with different hyaluronan modifi-
cations.  
The CDH-modified gels withstood swelling better before breaking apart, presumably due 
to the more stable chemical bonds of their crosslinks, as described in Chapter 7.2. The 
stability of the ADH-modified gels was concluded insufficient, since they dissolved al-
ready within the first few hours when immersed in the medium. 
Apart from the differences between gel types, the tests showed that the behaviour of the 
lyophilised gels differed significantly from the ones tested right after gelation. The lyoph-
ilised samples maintained their constitution longer in the medium than the non-lyophi-
lised gels, which might result from the forming of physical bonds, such as chain entan-
glements or structural changes or failures. However, unlike the non-lyophilised samples, 
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the freeze-dried gels also deformed considerably during swelling, which might also indi-
cate a possible partial collapse of their structure. Interestingly, the lyophilisation also re-
versed the effect that collagen had on the swelling behaviour of the gels: the lyophilised 
non-collagenous gels seemed more resistant to swelling, while the fresh gels with colla-
gen showed improved persistence towards the absorption of the medium. 
It should be noted that the lyophilised samples do not accurately present the behaviour of 
the gels that would be used in cell culture experiments, since they are not intended to be 
dried prior to cell seeding. The results from the swelling tests of non-lyophilised gels can 
be therefore considered more useful, because they simulate the actual way the gels would 
be used in practice. However, the measurements for the lyophilised gels were significant 
as well, since they showed the great impact lyophilisation had on gel swelling and stabil-
ity. This was also supported by the fact that the gels did not seem to recover their initial 
mass at the point where the swelling had reached an apparent equilibrium. Even though 
the reasons for the changes caused by freeze-drying were not clear, the results were rele-
vant regarding for example the possible storage and transportation of the gels. 
Enzymatic degradation 
The main purpose of the enzymatic degradation test was to ensure that the modifications 
of hyaluronan had not made it unrecognisable to the hyaluronidase enzymes, which are 
one of the main factors for implant degradation. All the gels degraded as expected, mean-
ing that the molecule structure had not changed in this aspect. In practice, the gels unrec-
ognised by the enzymes would have remained nondegraded and behaved as they did in 
the swelling experiments.  
The gels of type B withstood hyaluronidase degradation considerably longer than the type 
A, and experienced rather stable degradation. As time passed, type B samples decreased 
in size at a stable rate, which visually resembled the mechanism of surface erosion. Type 
A gels seemed to deform more as they degraded. The difference was not radical, but it 
might have resulted from the higher crosslink density and improved hydrolytic stability 
of the CDH-modified gels. 
A notable observation is that the masses of all type B samples remained very high 
throughout the testing, with almost 98 % of their original mass still remaining after 28 
hours. This meant a mere 2.0–2.4 percentage point change in mass from time point 0 to 
28 hours. After this, all the samples had completely degraded within the next 20 hours, 
leading to the conclusion that the degradation rate in fact increased towards the end of the 
experiment. Similar behaviour can be seen in type A gels, with almost 100 % gel mass 
remaining after 6 hours, and complete degradation occurring before the 24-hour time 
point. However, because there is rather a long time-gap between time points 6 h and 24 h 
compared to the data obtained from the time before that (0–6 h), it might not be reliable 
to draw similar conclusions from gel type A based on this test. 
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When considering the differences that lyophilisation had on immersed gel behaviour, as 
discussed in Chapter 8.1.4, it would have been an interesting experiment to include the 
lyophilised gel samples also in the enzymatic degradation tests. If the HAse enzymes 
would still recognise the hyaluronan molecules, lyophilisation could be used to improve 
gel stability by decreasing their swelling rate in the medium. The freeze-drying, of course, 
might cause problems with how easily the cells and nutrients can move inside the hydro-
gels during cell culturing. Similar swelling/stability test would could also be carried out 
with gels that have already corneal cells cultured within to examine what effect the cells 
have on hydrogel stability and swelling behaviour. 
9.1.3 Effects of collagen on mechanical performance and cell vi-
ability 
Collagen plays a major role as a structural component in the native corneal tissue, which 
is why it was included as one of the gel component. Due to its ability to form bonds with 
the aldehyde modified hyaluronan components, collagen was also intended to improve 
the mechanical resilience of the hydrogels.  
As presented in Chapter 8.3.1, the mechanical strength of the collagenous gel B2 (HA-
ALD2 (30) + HA-CDH (30)) was higher than the one of gel B1 (HA-ALD2 (30) + HA-
CDH (30) + Rat tail collagen I (2)) without collagen. In contrary, the collagen-containing 
gel A2 (HA-ALD1 (22.5) + HA-ADH (11.25) + Rat tail collagen I (2)) was significantly 
weaker than the collagen-free gel A1 (HA-ALD1 (20) + HA-ADH (10)). The average 
value of the second-order elastic constant of gel A1 (5.4 ± 1.1 kPa) was over 60 % higher 
than the one of A2 (2.9 ± 1.1 kPa), while the value of B2 (7.3 ± 1.7 kPa) was about 9 % 
higher than the one of B1 (6.7 ± 1.0 kPa). Therefore, the addition of collagen improved 
the mechanical properties in CDH-modified gels, but had a rather radical opposite effect 
on the ones with ADH-modification. Collagen was suspected to reinforce type B gels by 
forming additional crosslinks, while distracting the actual crosslinking of HA in type A 
gels. 
The rat tail collagen I used in gels A2 and B2 showed satisfactory cell viability, with both 
live and dead cells in the suspension on the third day. The collagen-free gels A1 and B1 
performed better, with only very few dead cells at the same time point. Another notable 
feature of the neutralised rat collagen solution was that it did not form a gel on its own 
when placed in the incubator – opposite to what was expected. Therefore, it is possible 
that the rat collagen solution had quality problems. However, within the scope of this 
thesis the reasons for poor collagen performance could not be studied further. 
The human collagen solution tested in the optimisation phase caused some undesired out-
come in the cell culture tests, which was why its use was discontinued. The human colla-
gen seemed to cause the cells to perish already within three days, with only dead cells 
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visible in the live/dead analysis. An unsuitable pH value was later concluded as the prob-
able cause, since a test with neutralised pH did not result in as many dead cells. However, 
like the rat collagen, the human collagen solution did not form a gel on its own, which 
indicated that there were other problems with the collagen as well. Both the rat and the 
human collagen were relatively old, which most probably had affected their quality. 
9.1.4 Gel biocompatibility 
The cell viability tests were carried out at certain points of the optimisation stage to guide 
the process of material development. All the cell culture tests were conducted by the Eye 
Group of BioMediTech in Tampere, Finland. The purpose of the tests was to get a first 
estimation of gel biocompatibility and their suitability in providing a scaffold for corneal 
cells. The optimal outcome was to observe cell orientation, stretching, functional metab-
olism and cell stratification throughout the structure of the gel. 
As described in Chapter 9.1.3, the collagens caused problems in the cell viability tests. 
Collagen I from human placenta tested in the optimisation phase turned out to be non-
compatible with cells, while the rat tail collagen I showed slightly decreased cell viability 
compared to the parallel collagen-free gels. Therefore, based on this study the gels with-
out collagen would be better suitable to be used for corneal regeneration. However, since 
it is possible that the quality of the collagen solutions affected the results, more tests 
should be done with newer collagen batches. 
Generally, the final gels showed sufficient properties to maintain cell growth, but did not 
induce the cells to orientate or to stretch along the collagen fibres, as was anticipated. 
Live cells remained on multiple levels of the gel, but tended to remain round-shaped and 
stationary. During time, more cells gathered on the bottom of the cultures, which indi-
cated that the cells possibly did not to find convenient anchoring points in the gel struc-
ture. Although the gels on their own did not principally promote cell growth, it could 
perhaps be induced with the addition of growth factors or other agents. 
The ADH-modified gels A1 and A2 provided weaker mechanical support for the cells 
than gels B1 and B2 with the stronger CDH-modified hydrazide component. During cell 
culturing the ADH-modified gels tended to weaken and dissolve prematurely, which is 
why the CDH-modified gels were a preferable option from this aspect too. In cell viabil-
ity, no significant differences were noticed between the gel types A and B. 
Nevertheless, none of the characterised gels exhibited cytotoxicity or other radical ad-
verse effects on cell growth, which was the essential requirement and the property exam-
ined in these tests. Based on the results, the hyaluronan hydrogels A1 and B1 could be-
come satisfactory scaffolds for tissue growth, while the gels A2 and B2 would still need 
improvements regarding the collagens. 
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9.2 Characterisation of the optical properties of hydrogels 
The optical clarity of the gels was evaluated visually during the optimisation phase as 
well as during different characterisations. Based on visual inspection, the tested gels 
showed sufficient transparency to be used for corneal implantation. As the gel clarity was 
evaluated and different methods were searched from literature, it was noticed that cur-
rently no standardised scientific testing protocol has been established for hydrogel trans-
parency measurements. Current methods often involve visual inspection, which is highly 
subjective and impossible to compare between different research groups. Images of gels 
with text in the background, which are often used, can merely show that the gels are not 
completely opaque, and can easily be modified through image editing programs. To pro-
duce more objective results and numeric data, a fibre spectrometer-based transmittance 
measurement method was developed along the characterisations. 
Some objective measurement methods have been described in literature to evaluate hy-
drogel transparency. These include for example ultraviolet-visible (UV-vis) spectroscopy 
and photography-based optical measurements and calculations (for example Gonzales-
Andrades et al., 2015). As described in Chapter 7.4.3, a portable spectrometer with fibre 
optics and a computer program to evaluate gel transmittance levels was used in this study. 
Preliminary results were obtained, and they were in accordance to the expectations. 
Transmittance data showed a difference between gels A1 and A2, confirming that colla-
gen-content actually decreased gel transparency, even though any difference could not be 
seen with the naked eye. However, further development is still necessary for the sample 
holder to ensure that both microscopy slides are completely parallel to the penetrating 
light beam. 
The system was first developed with only one microscopy glass and a PDMS membrane. 
However, when preparing the gels in the PDMS wells it was noticed that due to the ca-
pillary effect the hydrogels tended either to form convex lens-like shapes, with the centre 
being thicker than the periphery, or to ‘climb’ onto the walls of the PDMS well and form-
ing a concave surface. In both cases, it was impossible to maintain control of the gel 
thickness, which would be essential for the repetition of this type of optical measurement. 
The solution was to place a second microscopy glass and the metal spacers. By preparing 
the gel samples so that they remain in the convex shape, with their centre slightly thicker 
than the PDMS membrane, it was possible to squeeze the gels between the two glasses 
and achieve a uniform gel thickness. The metal spacers kept the distance between the 
glasses equal on both sides and were to keep them parallel.  
Even though the glasses were highly parallel, the light beam presumably reflected be-
tween the glasses and caused error in the results. To avoid light reflection between the 
slides, distilled water could be used instead or air as the reference. Water as a reference 
would have possibly decreased light reflection by lowering the differences in RI at the 
glass-intermediate interface. This idea, however, was not tested in practice due to the lack 
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of PDMS membrane with appropriate thickness. The membrane used in the measure-
ments was slightly thinner than the metal spacers, which worked well for the hydrogels 
but would have left a gap for the water to leak out from the PDMS well. Another im-
provement point would be a proper mount for the sample holder, which would keep it 
parallel to the light beam and attached to the spectrometer. The mount could be manufac-
tured for instance through 3D-printing, but due to the lack of time it could not be devel-
oped during this thesis. Additionally, to avoid error caused by stray light, a removable 
cover could be added on the mount. 
It was not concluded if finishing this custom design would guarantee reliable results, even 
though the idea seemed to function. An alternative option for fibre spectrometer meas-
urements would be the use of microliter-sized cuvettes. Since the fibre spectrometer was 
already equipped with a holder for a standard cuvette of 10 mm path length, it could be 
possible to do the measurements by using, for example, a 500 µl-volume microcuvette 
that would fit in the standard holder. However, the requirement for such cuvette would 
be a thin geometry for the sample compartment so that the measurement could be taken 
from a gel with similar thickness to the native cornea. In many microcuvettes, the sample 
chamber is thin, but the measurement is made in the longitudinal direction, which would 
not solve the problem. Therefore, the cuvette would need to be one with a possibility to 
measure in the transverse (thin sample) direction, having a clear window on all sides of 
the sample chamber. Compared to the custom apparatus, this method would have the ad-
vantage of being relatively free from sources of human error and being easily repeatable 
in other research groups as well. Unfortunately, there was no possibility to perform tests 
using this method during this thesis project. 
9.3 Transparency vs. biodegradability in tissue-engineered cor-
neal substitutes 
Compared to other characterisation methods, it seems that the transparency of hydrogels 
remains a slightly problematic property to measure. In the stage of material development 
of this thesis, transparency was also noticed to be a major limitation that prohibited the 
use of wide range of materials and designs, such as composite structures or higher con-
centrations of certain components.  
However, when considering the actual end use of the gel as a tissue engineered implant 
for corneal regeneration, it should be noted that even if the material was fully transparent 
at the moment of implantation, the postsurgical healing process would nevertheless re-
quire the eye to be covered for a certain time period. This awoke discussion about how 
important initial transparency actually is for a biodegradable ocular implant that is de-
signed to be replaced with ocular tissue in a relatively short period of time. In other words, 
what is the relationship between normal eyesight recovery time after an ocular surgery 
and the degradation time of a tissue-engineered hydrogel implant; is it possible to design 
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the implant to degrade during the limits of normal post-surgical recovery time of the eye-
sight? 
Relevant points of comparison for eyesight recovery times are traditional methods of ker-
atoplasty, the most common treatments for severe corneal traumas. These include full 
thickness corneal grafts, implanted using PK or through DALK, in which Descemet’s 
membrane and endothelium are left intact. However, because the in vivo degradation 
times of the materials developed in this study are not known due to the early stage of 
development, it is only possible to evaluate results found about similar materials from 
literature. 
In a review of 100 cases of PK done by Sutton et al. (2008), two months after the opera-
tion about 2/3 of the patients had recovered a best corrected visual acuity (BCVA) value 
of 6/12, which is half of the value of a healthy eye, while all the patients reached the value 
after 6 months. The average time to reach a the BCVA of 6/12 was 9,6 weeks. (Sutton et 
al., 2008) While the results presented in the review are very positive, it has also been 
reported (Anshu et al., 2012) that the recovery to a similar visual acuity level after a PK 
might take even 2 to 8 years. The outcome of is highly dependent on the individual and 
their history in corneal diseases. Generally, the eyes treated with PK often require a long 
follow-up period and have a relatively high graft failure rate of about 10 %. Over time, 
however, the successful cases of PK can often result in completely recovered BCVA of 
6/6. (Anshu et al., 2012) 
Based on the review by Sutton et al. it seems that the recovery of a functional level of 
eyesight after a PK takes at least two months. Hypothetically, if a tissue-engineered cor-
neal implant would begin to integrate into the corneal tissue during this time, there would 
be no need for the material to be transparent in the first place. The goal would be to 
observe increasing corneal clarity as the biomaterial degrades and integrates into the tis-
sue, and finally becoming completely clear and healed cornea. Basically, since the oper-
ation of implanting a foreign material into the corneal tissue would be alike the one of 
keratoplasty, the nature of the recovery process would possibly be similar as well. How-
ever, as the hydrogel implant is intended to contain cells seeded from the patient’s own 
eye, the biocompatibility of the material might be superior to a corneal transplant. 
The biodegradation time of a hydrogel for corneal regeneration depends on the polymer. 
For the hydrogels prepared in the experimental part of this thesis, the degradation is de-
signed to occur through hydrolysis and enzymatic degradation by corneal hyaluronidase 
and collagenase enzymes. Even though similar HA-HA hydrogels have not been tested in 
vivo, pre-clinical testing data is available from hydrogels prepared from other natural pol-
ymers such as collagen (Liu et al., 2008), chitosan and alginate (Liang et al., 2011). Even 
though the materials are not completely comparable, these studies with natural proteins 
could give some reference to predict how the hydrogels in this study would behave in 
vivo. 
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In their research, Liu et al. (2008) prepared a corneal substitute from recombinant human 
collagen and tested it in pig models through DALK. They reported minor haziness in the 
implants during the first weeks after implantation, but after 3 months the implants had 
become fully transparent. In this case, the implant was prepared from collagen, so instead 
of rapid degradation of the material the purpose was full integration of the implant into 
the host tissue, which Liu et al. observed 1 year after implantation. (Liu et al., 2008) Since 
collagen is the main structural component of the cornea, good tissue response could be 
expected. 
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10. CONCLUSIONS 
In this thesis, two types of hyaluronan-based hydrazone-crosslinked hydrogels were stud-
ied with and without the incorporation of collagen I. The hydrogel properties were char-
acterised using a wide variety of test methods, and their suitability to be used as materials 
for corneal regeneration was evaluated. 
The mechanical and viscoelastic properties of the hydrogels were examined using com-
pression testing and cone-and-plate rheometry. The refractive indices and optical clarity 
were determined with customized testing protocols using SPR equipment and a fibre 
spectrometer. The synthesized polymers were structurally characterised through FTIR 
spectroscopy. Stability and behaviour under physiological conditions was evaluated at 37 
ºC through swelling (DMEM) and enzymatic degradation tests (PBS). To assess hydrogel 
suitability for corneal implantation and to determine the requirements for further material 
development, cell viability tests were carried out by a collaborating research group. 
The hyaluronans were modified with aldehyde and hydrazide functionalities to enable 
them to form a three-dimensional gel networks in mild conditions through hydrazone 
crosslinking. Four hydrogels were chosen for the characterisations. The two components 
of type A gels were modified with an adipic acid dihydrazide (HA-ADH) reactive group 
and with a corresponding aldehyde-modified component (HA-ALD1). The components 
of type B gels were modified with a carbodihydrazide (HA-CDH) reactive group and with 
a complementary aldehyde-modified hyaluronan (HA-ALD2). Each of the two hydra-
zone-crosslinked gel types had a gel incorporated with rat tail collagen I and one without. 
Type B gels showed potential to be used as a scaffold for cell delivery, or as an in situ-
crosslinkable hydrogel to fix corneal tissue. The CDH-modified type B gels showed su-
perior mechanical properties compared to type A gels with the ADH modification, as well 
as better stability and controlled swelling in physiological conditions. The ADH-modified 
gels did not remain stable in the cell culture medium for longer than three days, which 
was considered insufficient. All the tested gels were recognised by the hyaluronidase en-
zymes, indicating that the material can degrade in the ocular tissue through natural mech-
anisms. Unexpectedly, the addition of collagen I weakened the mechanical properties in 
type A gels, but had the opposite effect on type B gels. The addition of collagen also 
increased the swelling of lyophilised type B gels, while decreasing the swelling of type 
A samples. Collagen content had the opposite effect on the non-lyophilised samples. 
However, any definite explanation for these results was not confirmed. 
Based on this study, the CDH-modified type B gels can be concluded to present the suf-
ficient biocompatibility, stability and mechanical and optical properties to be considered 
as a potential material for corneal regeneration. 
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APPENDIX A: FTIR SPECTRA OF THE HYDROGEL COMPO-
NENTS 
The Appendix A consists of the FTIR curves of all the hyaluronan components used in 
this study. The curves of the unmodified hyaluronan, the aldehyde modified components 
HA-ALD1 and HA-ALD2, the hydrazide modified components HA-ADH and HA-CDH 
and the rat tail collagen I are presented below in Figures S1, S2, S3 and S4, in respective 
order. 
Figure S1. The FTIR spectrum of the unmodified hyaluronan. 
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Figure S2. The FTIR spectra of the aldehyde-modified hyaluronan components HA-
ALD1 and HA-ALD2. 
Figure S3. The FTIR spectra of the hydrazide-modified hyaluronan components HA-
ADH and HA-CDH. 
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Figure S4. FTIR spectrum of rat tail collagen I. 
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